microRNA information: hsa-miR-338-3p
| Section | ID | link |
|---|---|---|
| Mature name: | hsa-miR-338-3p | miRbase |
| Accession: | MIMAT0000763 | miRbase |
| Precursor name: | hsa-mir-338 | miRbase |
| Precursor accession: | MI0000814 | miRbase |
| Symbol: | MIR338 | HGNC |
| RefSeq ID: | NR_029897 | GenBank |
| Sequence: | UCCAGCAUCAGUGAUUUUGUUG |
Reported expression in cancers: hsa-miR-338-3p
| miRNA | cancer | regulation | reporting | PUBMED | method |
|---|---|---|---|---|---|
| hsa-miR-338-3p | colorectal cancer | downregulation | "miR-338-3p is a recently discovered miRNA and is i ......" | 24824250 | Northern blot; Reverse transcription PCR; qPCR |
| hsa-miR-338-3p | esophageal cancer | deregulation | "In this study differentially expressed miRNAs in t ......" | 23124769 | Microarray; Reverse transcription PCR; qPCR |
| hsa-miR-338-3p | esophageal cancer | deregulation | "When ESCC patients were grouped according to their ......" | 24039884 | |
| hsa-miR-338-3p | gastric cancer | downregulation | "Here we report that miR-338-3p was epigenetically ......" | 23826132 | |
| hsa-miR-338-3p | gastric cancer | downregulation | "Although miR-338-3p has been implicated in hepatoc ......" | 24375644 | |
| hsa-miR-338-3p | gastric cancer | downregulation | "Although miR-338-3p has been implicated in several ......" | 26617808 | qPCR |
| hsa-miR-338-3p | liver cancer | downregulation | "Bead based microarray analysis of microRNA express ......" | 19473441 | Microarray; Reverse transcription PCR; qPCR |
| hsa-miR-338-3p | liver cancer | downregulation | "miR 338 3p suppresses invasion of liver cancer cel ......" | 21671467 | |
| hsa-miR-338-3p | liver cancer | downregulation | "Previous studies suggested microRNA-338-3p miR-338 ......" | 25755720 | |
| hsa-miR-338-3p | lung cancer | downregulation | "miR-338-3p was shown to be downregulated in NSCLC ......" | 25374067 | |
| hsa-miR-338-3p | lung cancer | downregulation | "In the present study we demonstrated that miR-338- ......" | 27186391 | |
| hsa-miR-338-3p | lung cancer | downregulation | "In the present study we found that miR-338 was str ......" | 27431198 | |
| hsa-miR-338-3p | ovarian cancer | downregulation | "MiR 338 3p targets pyruvate kinase M2 and affects ......" | 27508048 | |
| hsa-miR-338-3p | sarcoma | upregulation | "We confirmed the results of the microarray analysi ......" | 23574781 | Reverse transcription PCR; Microarray |
Reported cancer pathway affected by hsa-miR-338-3p
| miRNA | cancer | pathway | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-338-3p | breast cancer | cell cycle pathway; Apoptosis pathway | "MicroRNA 338 3p functions as tumor suppressor in b ......" | 26252944 | Western blot; Luciferase; Colony formation |
| hsa-miR-338-3p | colorectal cancer | Apoptosis pathway | "To investigate the regulative effect of miRNA-338- ......" | 23599646 | Flow cytometry; Western blot |
| hsa-miR-338-3p | esophageal cancer | Apoptosis pathway | "MicroRNA 338 3p suppresses tumor growth of esophag ......" | 26004521 | Colony formation |
| hsa-miR-338-3p | gastric cancer | Apoptosis pathway | "Epigenetic silencing of miR 338 3p contributes to ......" | 23826132 | |
| hsa-miR-338-3p | gastric cancer | Apoptosis pathway; PI3K/Akt signaling pathway | "miR 338 3p suppresses gastric cancer progression t ......" | 24375644 | |
| hsa-miR-338-3p | gastric cancer | Apoptosis pathway | "MicroRNA 338 inhibits growth invasion and metastas ......" | 24736504 | |
| hsa-miR-338-3p | gastric cancer | PI3K/Akt signaling pathway; Epithelial mesenchymal transition pathway | "MiR 338 3p inhibits epithelial mesenchymal transit ......" | 25945841 | |
| hsa-miR-338-3p | liver cancer | cell cycle pathway | "MicroRNA 338 3p inhibits cell proliferation in hep ......" | 25755720 | Colony formation |
| hsa-miR-338-3p | lung cancer | Apoptosis pathway | "microRNA 338 3p functions as a tumor suppressor in ......" | 25374067 | Colony formation; Luciferase |
| hsa-miR-338-3p | lung cancer | Apoptosis pathway | "miR 338 inhibits the metastasis of lung cancer by ......" | 27431198 | |
| hsa-miR-338-3p | lung squamous cell cancer | Epithelial mesenchymal transition pathway | "miR 338 3p suppresses epithelial mesenchymal trans ......" | 27453416 | Transwell assay; Luciferase |
Reported cancer prognosis affected by hsa-miR-338-3p
| miRNA | cancer | prognosis | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-338-3p | breast cancer | staging | "Global miRNA analysis was performed on prospective ......" | 25004125 | |
| hsa-miR-338-3p | breast cancer | staging | "MicroRNA 338 3p functions as tumor suppressor in b ......" | 26252944 | Western blot; Luciferase; Colony formation |
| hsa-miR-338-3p | colorectal cancer | differentiation; progression; poor survival; staging; worse prognosis | "miR-338-3p is a recently discovered miRNA and is i ......" | 24824250 | Western blot; Luciferase |
| hsa-miR-338-3p | esophageal cancer | poor survival | "When ESCC patients were grouped according to their ......" | 24039884 | |
| hsa-miR-338-3p | esophageal cancer | staging | "MicroRNA 338 3p suppresses tumor growth of esophag ......" | 26004521 | Colony formation |
| hsa-miR-338-3p | gastric cancer | poor survival | "Several microarray studies have reported microRNA ......" | 19951901 | |
| hsa-miR-338-3p | gastric cancer | progression | "miR 338 3p suppresses gastric cancer progression t ......" | 24375644 | |
| hsa-miR-338-3p | gastric cancer | metastasis; cell migration | "MicroRNA 338 inhibits growth invasion and metastas ......" | 24736504 | |
| hsa-miR-338-3p | gastric cancer | metastasis; progression | "MiR 338 3p inhibits epithelial mesenchymal transit ......" | 25945841 | |
| hsa-miR-338-3p | gastric cancer | progression; cell migration | "MiR 338 3p inhibits the proliferation and migratio ......" | 26617808 | MTT assay; Luciferase |
| hsa-miR-338-3p | glioblastoma | drug resistance; differentiation | "MiR 338 5p sensitizes glioblastoma cells to radiat ......" | 26692101 | |
| hsa-miR-338-3p | liver cancer | staging; metastasis; tumor size | "Bead based microarray analysis of microRNA express ......" | 19473441 | |
| hsa-miR-338-3p | liver cancer | metastasis | "Identification of metastasis related microRNAs of ......" | 19912688 | |
| hsa-miR-338-3p | liver cancer | cell migration | "miR 338 3p suppresses invasion of liver cancer cel ......" | 21671467 | |
| hsa-miR-338-3p | liver cancer | poor survival | "MicroRNA 338 3p inhibits cell proliferation in hep ......" | 25755720 | Colony formation |
| hsa-miR-338-3p | liver cancer | progression | "Mineralocorticoid receptor suppresses cancer progr ......" | 26082033 | |
| hsa-miR-338-3p | lung cancer | staging; metastasis; differentiation | "microRNA 338 3p functions as a tumor suppressor in ......" | 25374067 | Colony formation; Luciferase |
| hsa-miR-338-3p | lung cancer | metastasis | "MicroRNA 338 3p suppresses metastasis of lung canc ......" | 27186391 | |
| hsa-miR-338-3p | lung cancer | metastasis; staging; poor survival; recurrence | "miR 338 inhibits the metastasis of lung cancer by ......" | 27431198 | |
| hsa-miR-338-3p | lung cancer | metastasis | "Erratum: MicroRNA 338 3p suppresses metastasis of ......" | 27508100 | |
| hsa-miR-338-3p | lung squamous cell cancer | metastasis | "miR 338 3p suppresses epithelial mesenchymal trans ......" | 27453416 | Transwell assay; Luciferase |
| hsa-miR-338-3p | ovarian cancer | metastasis | "MiR 338 3p targets pyruvate kinase M2 and affects ......" | 27508048 | Luciferase |
Reported gene related to hsa-miR-338-3p
| miRNA | cancer | gene | reporting | PUBMED |
|---|---|---|---|---|
| hsa-miR-338-3p | colorectal cancer | SMO | "Smoothened SMO possible target of miR-338-3p mRNA ......" | 24824250 |
| hsa-miR-338-3p | colorectal cancer | SMO | "Moreover the expression of miR-338-3p was determin ......" | 23599646 |
| hsa-miR-338-3p | liver cancer | SMO | "Furthermore smoothened SMO was identified as a dir ......" | 21671467 |
| hsa-miR-338-3p | breast cancer | SOX4 | "MicroRNA 338 3p functions as tumor suppressor in b ......" | 26252944 |
| hsa-miR-338-3p | lung cancer | SOX4 | "Erratum: MicroRNA 338 3p suppresses metastasis of ......" | 27508100 |
| hsa-miR-338-3p | lung cancer | SOX4 | "MicroRNA 338 3p suppresses metastasis of lung canc ......" | 27186391 |
| hsa-miR-338-3p | gastric cancer | MACC1 | "MiR-338-3p repressed the Met/Akt pathway after MAC ......" | 25945841 |
| hsa-miR-338-3p | liver cancer | MACC1 | "Moreover MACC1 is predicted to be a target of miR- ......" | 27694002 |
| hsa-miR-338-3p | gastric cancer | ZEB2 | "MiR 338 3p inhibits epithelial mesenchymal transit ......" | 25945841 |
| hsa-miR-338-3p | lung squamous cell cancer | ZEB2 | "Dual-luciferase reporter assay was finally perform ......" | 27453416 |
| hsa-miR-338-3p | gastric cancer | ADAM17 | "MiR 338 3p inhibits the proliferation and migratio ......" | 26617808 |
| hsa-miR-338-3p | liver cancer | CAMKMT | "Then the tube formation transwell and Chorioallant ......" | 27694002 |
| hsa-miR-338-3p | lung cancer | CD82 | "Among these miRNAs CD82 caused upregulation of miR ......" | 26132195 |
| hsa-miR-338-3p | liver cancer | FOXP4 | "Using bio-informatic method and report assay we id ......" | 25755720 |
| hsa-miR-338-3p | lung cancer | ITGA9 | "miR 338 inhibits the metastasis of lung cancer by ......" | 27431198 |
| hsa-miR-338-3p | lung cancer | ITGB3 | "Furthermore we also identified a metastasis relate ......" | 27431198 |
| hsa-miR-338-3p | gastric cancer | MECP2 | "MECP2 promotes the growth of gastric cancer cells ......" | 27166996 |
| hsa-miR-338-3p | liver cancer | NR3C2 | "Mineralocorticoid receptor suppresses cancer progr ......" | 26082033 |
| hsa-miR-338-3p | gastric cancer | NRP1 | "MicroRNA 338 inhibits growth invasion and metastas ......" | 24736504 |
| hsa-miR-338-3p | liver cancer | PKLR | "Mineralocorticoid receptor suppresses cancer progr ......" | 26082033 |
| hsa-miR-338-3p | ovarian cancer | PKM | "PKM2 was verified as a target gene of miR-338-3p b ......" | 27508048 |
| hsa-miR-338-3p | gastric cancer | PREX2 | "Furthermore P-Rex2a PREX2 was identified as a dire ......" | 24375644 |
| hsa-miR-338-3p | gastric cancer | PTEN | "miR 338 3p suppresses gastric cancer progression t ......" | 24375644 |
| hsa-miR-338-3p | lung cancer | RASD1 | "microRNA 338 3p functions as a tumor suppressor in ......" | 25374067 |
| hsa-miR-338-3p | gastric cancer | SSX2IP | "Epigenetic silencing of miR 338 3p contributes to ......" | 23826132 |
| hsa-miR-338-3p | lung squamous cell cancer | TCF12 | "Dual-luciferase reporter assay was finally perform ......" | 27453416 |
| hsa-miR-338-3p | glioblastoma | TUBA1A | "MiR-338 is a brain-specific miRNA which has been d ......" | 26692101 |
| hsa-miR-338-3p | liver cancer | VEGFA | "And then our research showed that negative correla ......" | 27694002 |
Expression profile in cancer corhorts:
Putative target regulations
| miRNA | Gene | Cancer | Interaction | Correlation beta |
|---|---|---|---|---|
hsa-miR-338-3p | ZNF217 | 10 cancers: BLCA; BRCA; HNSC; KIRP; LGG; LUSC; OV; PAAD; PRAD; THCA | MirTarget; miRanda | TCGA BLCA -0.148; TCGA BRCA -0.05; TCGA HNSC -0.216; TCGA KIRP -0.193; TCGA LGG -0.168; TCGA LUSC -0.161; TCGA OV -0.07; TCGA PAAD -0.303; TCGA PRAD -0.162; TCGA THCA -0.249 |
hsa-miR-338-3p | SLC35F5 | 11 cancers: BLCA; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD | MirTarget; PITA; miRanda | TCGA BLCA -0.055; TCGA COAD -0.091; TCGA HNSC -0.115; TCGA KIRC -0.21; TCGA KIRP -0.127; TCGA LGG -0.116; TCGA LIHC -0.06; TCGA LUAD -0.088; TCGA LUSC -0.054; TCGA PAAD -0.155; TCGA PRAD -0.181 |
hsa-miR-338-3p | SH3D19 | 10 cancers: BLCA; BRCA; CESC; HNSC; KIRP; LIHC; PAAD; PRAD; SARC; THCA | MirTarget; miRanda | TCGA BLCA -0.122; TCGA BRCA -0.085; TCGA CESC -0.066; TCGA HNSC -0.086; TCGA KIRP -0.087; TCGA LIHC -0.2; TCGA PAAD -0.241; TCGA PRAD -0.103; TCGA SARC -0.162; TCGA THCA -0.053 |
hsa-miR-338-3p | ZBTB10 | 12 cancers: BLCA; BRCA; COAD; HNSC; LGG; LIHC; LUAD; OV; PRAD; SARC; THCA; STAD | MirTarget; PITA; miRanda; miRNATAP | TCGA BLCA -0.187; TCGA BRCA -0.068; TCGA COAD -0.362; TCGA HNSC -0.264; TCGA LGG -0.122; TCGA LIHC -0.149; TCGA LUAD -0.213; TCGA OV -0.116; TCGA PRAD -0.225; TCGA SARC -0.198; TCGA THCA -0.166; TCGA STAD -0.219 |
hsa-miR-338-3p | ACVR1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; UCEC | MirTarget; PITA; miRanda; miRNATAP | TCGA BLCA -0.066; TCGA BRCA -0.082; TCGA CESC -0.113; TCGA COAD -0.066; TCGA ESCA -0.161; TCGA HNSC -0.204; TCGA LGG -0.057; TCGA LUAD -0.055; TCGA LUSC -0.131; TCGA PAAD -0.155; TCGA PRAD -0.074; TCGA SARC -0.126; TCGA THCA -0.171; TCGA UCEC -0.092 |
hsa-miR-338-3p | CELSR2 | 9 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LUSC; SARC; THCA; STAD | MirTarget; PITA; miRanda | TCGA BLCA -0.166; TCGA CESC -0.194; TCGA ESCA -0.623; TCGA HNSC -0.189; TCGA KIRP -0.165; TCGA LUSC -0.428; TCGA SARC -0.202; TCGA THCA -0.154; TCGA STAD -0.174 |
hsa-miR-338-3p | NNT | 9 cancers: BLCA; HNSC; KIRC; LIHC; LUAD; LUSC; PRAD; SARC; THCA | MirTarget; PITA; miRanda | TCGA BLCA -0.089; TCGA HNSC -0.091; TCGA KIRC -0.339; TCGA LIHC -0.168; TCGA LUAD -0.073; TCGA LUSC -0.137; TCGA PRAD -0.084; TCGA SARC -0.157; TCGA THCA -0.075 |
hsa-miR-338-3p | ENAH | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.063; TCGA BRCA -0.134; TCGA CESC -0.121; TCGA COAD -0.19; TCGA ESCA -0.28; TCGA HNSC -0.17; TCGA KIRP -0.083; TCGA LGG -0.106; TCGA LUAD -0.125; TCGA LUSC -0.176; TCGA PAAD -0.237; TCGA PRAD -0.075; TCGA SARC -0.263; TCGA THCA -0.195; TCGA STAD -0.12 |
hsa-miR-338-3p | KCND2 | 9 cancers: BLCA; ESCA; HNSC; LUAD; LUSC; OV; PAAD; THCA; UCEC | MirTarget; PITA; miRanda | TCGA BLCA -0.181; TCGA ESCA -0.62; TCGA HNSC -0.262; TCGA LUAD -0.279; TCGA LUSC -0.414; TCGA OV -0.157; TCGA PAAD -0.307; TCGA THCA -0.426; TCGA UCEC -0.14 |
hsa-miR-338-3p | ZNF436 | 11 cancers: BLCA; CESC; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | PITA; miRanda | TCGA BLCA -0.221; TCGA CESC -0.191; TCGA ESCA -0.281; TCGA HNSC -0.133; TCGA LGG -0.082; TCGA LUAD -0.071; TCGA LUSC -0.129; TCGA PAAD -0.129; TCGA PRAD -0.114; TCGA STAD -0.1; TCGA UCEC -0.065 |
hsa-miR-338-3p | DLG2 | 11 cancers: BLCA; BRCA; CESC; COAD; KIRC; LIHC; LUAD; PRAD; SARC; STAD; UCEC | PITA; mirMAP; miRNATAP | TCGA BLCA -0.246; TCGA BRCA -0.13; TCGA CESC -0.313; TCGA COAD -0.362; TCGA KIRC -0.284; TCGA LIHC -0.258; TCGA LUAD -0.081; TCGA PRAD -0.204; TCGA SARC -0.298; TCGA STAD -0.378; TCGA UCEC -0.286 |
hsa-miR-338-3p | PPP1CB | 12 cancers: BLCA; BRCA; ESCA; KIRC; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA | PITA; miRanda | TCGA BLCA -0.101; TCGA BRCA -0.055; TCGA ESCA -0.16; TCGA KIRC -0.069; TCGA LGG -0.066; TCGA LUAD -0.072; TCGA LUSC -0.098; TCGA OV -0.061; TCGA PAAD -0.089; TCGA PRAD -0.101; TCGA SARC -0.19; TCGA THCA -0.114 |
hsa-miR-338-3p | BCL9 | 10 cancers: BLCA; BRCA; COAD; HNSC; KIRC; LGG; LUSC; PRAD; SARC; STAD | PITA; miRanda; miRNATAP | TCGA BLCA -0.093; TCGA BRCA -0.07; TCGA COAD -0.052; TCGA HNSC -0.209; TCGA KIRC -0.173; TCGA LGG -0.054; TCGA LUSC -0.16; TCGA PRAD -0.135; TCGA SARC -0.186; TCGA STAD -0.068 |
hsa-miR-338-3p | IDE | 10 cancers: BLCA; BRCA; HNSC; KIRC; LGG; LUSC; PAAD; PRAD; SARC; THCA | PITA; miRanda | TCGA BLCA -0.127; TCGA BRCA -0.061; TCGA HNSC -0.175; TCGA KIRC -0.091; TCGA LGG -0.077; TCGA LUSC -0.129; TCGA PAAD -0.195; TCGA PRAD -0.239; TCGA SARC -0.068; TCGA THCA -0.165 |
hsa-miR-338-3p | RAB33B | 11 cancers: BLCA; BRCA; CESC; HNSC; KIRP; LIHC; LUAD; PRAD; SARC; THCA; UCEC | PITA; miRanda | TCGA BLCA -0.074; TCGA BRCA -0.073; TCGA CESC -0.062; TCGA HNSC -0.076; TCGA KIRP -0.052; TCGA LIHC -0.159; TCGA LUAD -0.058; TCGA PRAD -0.117; TCGA SARC -0.165; TCGA THCA -0.085; TCGA UCEC -0.068 |
hsa-miR-338-3p | TANC1 | 9 cancers: BLCA; BRCA; HNSC; LGG; PAAD; PRAD; SARC; THCA; UCEC | PITA; miRanda; miRNATAP | TCGA BLCA -0.072; TCGA BRCA -0.134; TCGA HNSC -0.153; TCGA LGG -0.105; TCGA PAAD -0.164; TCGA PRAD -0.066; TCGA SARC -0.167; TCGA THCA -0.204; TCGA UCEC -0.053 |
hsa-miR-338-3p | ZBTB20 | 10 cancers: BLCA; BRCA; HNSC; KIRP; LGG; LIHC; PRAD; SARC; THCA; UCEC | miRanda | TCGA BLCA -0.179; TCGA BRCA -0.131; TCGA HNSC -0.275; TCGA KIRP -0.272; TCGA LGG -0.23; TCGA LIHC -0.145; TCGA PRAD -0.191; TCGA SARC -0.249; TCGA THCA -0.097; TCGA UCEC -0.149 |
hsa-miR-338-3p | SPOCK3 | 10 cancers: BLCA; BRCA; CESC; ESCA; LIHC; LUAD; LUSC; PRAD; THCA; STAD | miRanda | TCGA BLCA -0.461; TCGA BRCA -0.155; TCGA CESC -0.272; TCGA ESCA -1.092; TCGA LIHC -0.367; TCGA LUAD -0.26; TCGA LUSC -0.453; TCGA PRAD -0.137; TCGA THCA -0.494; TCGA STAD -0.402 |
hsa-miR-338-3p | AKR1C2 | 9 cancers: BLCA; CESC; ESCA; KIRC; KIRP; LIHC; LUSC; PAAD; UCEC | miRanda | TCGA BLCA -0.305; TCGA CESC -0.579; TCGA ESCA -0.995; TCGA KIRC -0.423; TCGA KIRP -0.335; TCGA LIHC -0.316; TCGA LUSC -0.612; TCGA PAAD -0.377; TCGA UCEC -0.229 |
hsa-miR-338-3p | MID1 | 11 cancers: BLCA; BRCA; CESC; HNSC; KIRP; LGG; LUAD; PAAD; SARC; STAD; UCEC | miRanda | TCGA BLCA -0.225; TCGA BRCA -0.229; TCGA CESC -0.156; TCGA HNSC -0.118; TCGA KIRP -0.185; TCGA LGG -0.132; TCGA LUAD -0.071; TCGA PAAD -0.099; TCGA SARC -0.151; TCGA STAD -0.097; TCGA UCEC -0.091 |
hsa-miR-338-3p | TUSC3 | 9 cancers: BLCA; ESCA; KIRC; KIRP; LUAD; LUSC; PRAD; THCA; STAD | miRanda | TCGA BLCA -0.166; TCGA ESCA -0.783; TCGA KIRC -0.283; TCGA KIRP -0.147; TCGA LUAD -0.117; TCGA LUSC -0.216; TCGA PRAD -0.051; TCGA THCA -0.134; TCGA STAD -0.183 |
hsa-miR-338-3p | NHLRC2 | 9 cancers: BLCA; BRCA; HNSC; LGG; LIHC; LUSC; PAAD; PRAD; THCA | miRanda | TCGA BLCA -0.114; TCGA BRCA -0.07; TCGA HNSC -0.204; TCGA LGG -0.133; TCGA LIHC -0.102; TCGA LUSC -0.052; TCGA PAAD -0.14; TCGA PRAD -0.302; TCGA THCA -0.163 |
hsa-miR-338-3p | GNB5 | 9 cancers: BLCA; COAD; ESCA; HNSC; KIRC; LUSC; SARC; STAD; UCEC | miRanda | TCGA BLCA -0.113; TCGA COAD -0.095; TCGA ESCA -0.155; TCGA HNSC -0.106; TCGA KIRC -0.142; TCGA LUSC -0.104; TCGA SARC -0.167; TCGA STAD -0.188; TCGA UCEC -0.169 |
hsa-miR-338-3p | SLC38A1 | 10 cancers: BLCA; BRCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA | miRanda | TCGA BLCA -0.134; TCGA BRCA -0.142; TCGA HNSC -0.124; TCGA KIRP -0.108; TCGA LUAD -0.141; TCGA LUSC -0.156; TCGA PAAD -0.159; TCGA PRAD -0.161; TCGA SARC -0.369; TCGA THCA -0.104 |
hsa-miR-338-3p | ZNF845 | 10 cancers: BLCA; BRCA; COAD; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; THCA | miRanda | TCGA BLCA -0.065; TCGA BRCA -0.069; TCGA COAD -0.154; TCGA HNSC -0.121; TCGA LGG -0.074; TCGA LUAD -0.057; TCGA LUSC -0.072; TCGA PAAD -0.083; TCGA PRAD -0.094; TCGA THCA -0.099 |
hsa-miR-338-3p | EYA2 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LUAD; LUSC; PAAD; SARC; THCA; STAD | miRanda | TCGA BLCA -0.278; TCGA BRCA -0.225; TCGA CESC -0.407; TCGA COAD -0.253; TCGA ESCA -0.324; TCGA KIRC -0.475; TCGA LUAD -0.287; TCGA LUSC -0.379; TCGA PAAD -0.635; TCGA SARC -0.155; TCGA THCA -0.187; TCGA STAD -0.355 |
hsa-miR-338-3p | PHF20L1 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD | miRanda; miRNATAP | TCGA BLCA -0.067; TCGA CESC -0.08; TCGA COAD -0.082; TCGA ESCA -0.081; TCGA HNSC -0.086; TCGA LUAD -0.063; TCGA LUSC -0.08; TCGA OV -0.111; TCGA PAAD -0.132; TCGA PRAD -0.089 |
hsa-miR-338-3p | DCAF17 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC | miRanda | TCGA BLCA -0.078; TCGA CESC -0.07; TCGA COAD -0.065; TCGA ESCA -0.05; TCGA HNSC -0.128; TCGA KIRC -0.155; TCGA KIRP -0.075; TCGA LUAD -0.054; TCGA LUSC -0.141; TCGA PAAD -0.084; TCGA PRAD -0.113; TCGA SARC -0.084 |
hsa-miR-338-3p | COBLL1 | 11 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LIHC; PRAD; SARC; THCA; UCEC | miRanda | TCGA BLCA -0.257; TCGA BRCA -0.103; TCGA CESC -0.304; TCGA HNSC -0.134; TCGA KIRC -0.555; TCGA KIRP -0.185; TCGA LIHC -0.253; TCGA PRAD -0.181; TCGA SARC -0.329; TCGA THCA -0.178; TCGA UCEC -0.186 |
hsa-miR-338-3p | ELF5 | 9 cancers: BLCA; BRCA; CESC; COAD; KIRC; PAAD; PRAD; STAD; UCEC | miRanda | TCGA BLCA -0.27; TCGA BRCA -0.469; TCGA CESC -0.331; TCGA COAD -0.62; TCGA KIRC -1.993; TCGA PAAD -0.669; TCGA PRAD -0.159; TCGA STAD -0.338; TCGA UCEC -0.336 |
hsa-miR-338-3p | CLASP1 | 9 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LUSC; PRAD; SARC; STAD | miRanda | TCGA BLCA -0.105; TCGA CESC -0.055; TCGA ESCA -0.163; TCGA HNSC -0.146; TCGA KIRP -0.078; TCGA LUSC -0.156; TCGA PRAD -0.071; TCGA SARC -0.099; TCGA STAD -0.084 |
hsa-miR-338-3p | USP53 | 9 cancers: BLCA; BRCA; KIRC; LIHC; OV; PAAD; PRAD; THCA; UCEC | miRanda | TCGA BLCA -0.169; TCGA BRCA -0.11; TCGA KIRC -0.26; TCGA LIHC -0.16; TCGA OV -0.176; TCGA PAAD -0.158; TCGA PRAD -0.171; TCGA THCA -0.176; TCGA UCEC -0.118 |
hsa-miR-338-3p | ZNF28 | 10 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LGG; LUAD; OV; PRAD; THCA | miRanda | TCGA BLCA -0.086; TCGA BRCA -0.086; TCGA COAD -0.145; TCGA HNSC -0.142; TCGA KIRP -0.096; TCGA LGG -0.122; TCGA LUAD -0.062; TCGA OV -0.056; TCGA PRAD -0.156; TCGA THCA -0.187 |
hsa-miR-338-3p | DGKH | 10 cancers: BLCA; BRCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA | miRanda | TCGA BLCA -0.255; TCGA BRCA -0.238; TCGA HNSC -0.186; TCGA KIRP -0.225; TCGA LUAD -0.064; TCGA LUSC -0.126; TCGA PAAD -0.152; TCGA PRAD -0.151; TCGA SARC -0.1; TCGA THCA -0.385 |
hsa-miR-338-3p | LPP | 13 cancers: BLCA; BRCA; HNSC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; UCEC | miRanda; mirMAP | TCGA BLCA -0.279; TCGA BRCA -0.171; TCGA HNSC -0.328; TCGA KIRP -0.132; TCGA LGG -0.163; TCGA LUAD -0.086; TCGA LUSC -0.063; TCGA OV -0.058; TCGA PAAD -0.354; TCGA PRAD -0.331; TCGA SARC -0.453; TCGA THCA -0.163; TCGA UCEC -0.112 |
hsa-miR-338-3p | FOXP2 | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LIHC; PRAD; STAD; UCEC | miRanda | TCGA BLCA -0.356; TCGA BRCA -0.302; TCGA COAD -0.52; TCGA ESCA -0.808; TCGA HNSC -0.439; TCGA LIHC -0.497; TCGA PRAD -0.204; TCGA STAD -0.358; TCGA UCEC -0.376 |
hsa-miR-338-3p | SLC39A6 | 9 cancers: BLCA; ESCA; HNSC; KIRC; LUAD; LUSC; PRAD; THCA; UCEC | miRanda | TCGA BLCA -0.126; TCGA ESCA -0.428; TCGA HNSC -0.133; TCGA KIRC -0.132; TCGA LUAD -0.07; TCGA LUSC -0.195; TCGA PRAD -0.079; TCGA THCA -0.15; TCGA UCEC -0.081 |
hsa-miR-338-3p | MYO3B | 13 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | miRanda | TCGA BLCA -0.304; TCGA BRCA -0.225; TCGA COAD -0.276; TCGA ESCA -0.537; TCGA KIRC -1.199; TCGA LIHC -0.247; TCGA LUAD -0.355; TCGA LUSC -0.386; TCGA PAAD -0.565; TCGA PRAD -0.156; TCGA SARC -0.627; TCGA THCA -0.362; TCGA STAD -0.182 |
hsa-miR-338-3p | PTPN13 | 9 cancers: BLCA; CESC; ESCA; HNSC; KIRC; KIRP; PAAD; PRAD; STAD | miRanda | TCGA BLCA -0.375; TCGA CESC -0.353; TCGA ESCA -0.878; TCGA HNSC -0.112; TCGA KIRC -0.337; TCGA KIRP -0.15; TCGA PAAD -0.14; TCGA PRAD -0.152; TCGA STAD -0.304 |
hsa-miR-338-3p | PAPOLG | 9 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUSC; PAAD; PRAD | miRanda | TCGA BLCA -0.064; TCGA BRCA -0.053; TCGA CESC -0.091; TCGA COAD -0.075; TCGA ESCA -0.105; TCGA HNSC -0.17; TCGA LUSC -0.147; TCGA PAAD -0.074; TCGA PRAD -0.097 |
hsa-miR-338-3p | TTLL5 | 10 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC | miRanda | TCGA BLCA -0.069; TCGA CESC -0.056; TCGA ESCA -0.108; TCGA HNSC -0.139; TCGA KIRP -0.1; TCGA LUAD -0.054; TCGA LUSC -0.059; TCGA PAAD -0.063; TCGA PRAD -0.082; TCGA SARC -0.093 |
hsa-miR-338-3p | EXOC5 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; PRAD; SARC; THCA | miRanda | TCGA BLCA -0.062; TCGA CESC -0.056; TCGA COAD -0.054; TCGA ESCA -0.157; TCGA HNSC -0.132; TCGA LIHC -0.057; TCGA LUAD -0.105; TCGA PRAD -0.117; TCGA SARC -0.071; TCGA THCA -0.113 |
hsa-miR-338-3p | ATF2 | 10 cancers: BLCA; BRCA; COAD; HNSC; LIHC; LUSC; PAAD; PRAD; SARC; THCA | miRanda | TCGA BLCA -0.085; TCGA BRCA -0.062; TCGA COAD -0.081; TCGA HNSC -0.31; TCGA LIHC -0.104; TCGA LUSC -0.075; TCGA PAAD -0.143; TCGA PRAD -0.212; TCGA SARC -0.106; TCGA THCA -0.114 |
hsa-miR-338-3p | MAST4 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; PRAD; SARC; THCA; STAD; UCEC | miRanda | TCGA BLCA -0.318; TCGA CESC -0.128; TCGA COAD -0.104; TCGA ESCA -0.356; TCGA HNSC -0.194; TCGA PRAD -0.222; TCGA SARC -0.224; TCGA THCA -0.119; TCGA STAD -0.156; TCGA UCEC -0.194 |
hsa-miR-338-3p | PTPN21 | 9 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LGG; LIHC; PRAD; UCEC | miRanda | TCGA BLCA -0.126; TCGA BRCA -0.162; TCGA COAD -0.059; TCGA KIRC -0.097; TCGA KIRP -0.104; TCGA LGG -0.052; TCGA LIHC -0.076; TCGA PRAD -0.057; TCGA UCEC -0.073 |
hsa-miR-338-3p | PHLDB2 | 11 cancers: BLCA; COAD; ESCA; HNSC; KIRP; LGG; LUAD; SARC; THCA; STAD; UCEC | miRanda | TCGA BLCA -0.142; TCGA COAD -0.177; TCGA ESCA -0.639; TCGA HNSC -0.163; TCGA KIRP -0.135; TCGA LGG -0.07; TCGA LUAD -0.077; TCGA SARC -0.305; TCGA THCA -0.43; TCGA STAD -0.209; TCGA UCEC -0.185 |
hsa-miR-338-3p | ZNF365 | 9 cancers: BLCA; BRCA; CESC; ESCA; KIRC; OV; PRAD; THCA; STAD | miRanda | TCGA BLCA -0.184; TCGA BRCA -0.169; TCGA CESC -0.413; TCGA ESCA -0.879; TCGA KIRC -0.332; TCGA OV -0.11; TCGA PRAD -0.089; TCGA THCA -0.208; TCGA STAD -0.429 |
hsa-miR-338-3p | ZNF468 | 9 cancers: BLCA; BRCA; COAD; KIRC; LGG; LUAD; OV; PRAD; THCA | miRanda | TCGA BLCA -0.09; TCGA BRCA -0.071; TCGA COAD -0.092; TCGA KIRC -0.161; TCGA LGG -0.091; TCGA LUAD -0.058; TCGA OV -0.072; TCGA PRAD -0.121; TCGA THCA -0.145 |
hsa-miR-338-3p | REV3L | 9 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LGG; LIHC; PRAD; SARC | miRanda | TCGA BLCA -0.077; TCGA BRCA -0.094; TCGA COAD -0.098; TCGA HNSC -0.143; TCGA KIRP -0.156; TCGA LGG -0.107; TCGA LIHC -0.113; TCGA PRAD -0.099; TCGA SARC -0.195 |
hsa-miR-338-3p | TMEM19 | 9 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUSC; PRAD | miRanda | TCGA BLCA -0.115; TCGA CESC -0.187; TCGA COAD -0.071; TCGA ESCA -0.101; TCGA HNSC -0.079; TCGA KIRC -0.133; TCGA LIHC -0.117; TCGA LUSC -0.069; TCGA PRAD -0.067 |
hsa-miR-338-3p | NMD3 | 9 cancers: BLCA; HNSC; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; THCA | miRanda | TCGA BLCA -0.076; TCGA HNSC -0.076; TCGA LGG -0.069; TCGA LIHC -0.089; TCGA LUAD -0.097; TCGA LUSC -0.12; TCGA PAAD -0.129; TCGA PRAD -0.106; TCGA THCA -0.138 |
hsa-miR-338-3p | DVL3 | 9 cancers: BLCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; LUSC; SARC | miRanda | TCGA BLCA -0.083; TCGA CESC -0.07; TCGA ESCA -0.227; TCGA HNSC -0.203; TCGA KIRC -0.06; TCGA KIRP -0.058; TCGA LGG -0.089; TCGA LUSC -0.305; TCGA SARC -0.085 |
hsa-miR-338-3p | KLHL28 | 9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LIHC; LUAD; PRAD | miRanda | TCGA BLCA -0.125; TCGA BRCA -0.081; TCGA CESC -0.076; TCGA ESCA -0.075; TCGA HNSC -0.154; TCGA KIRP -0.09; TCGA LIHC -0.064; TCGA LUAD -0.057; TCGA PRAD -0.14 |
hsa-miR-338-3p | WEE1 | 12 cancers: BLCA; CESC; COAD; ESCA; KIRC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; UCEC | miRanda | TCGA BLCA -0.093; TCGA CESC -0.106; TCGA COAD -0.101; TCGA ESCA -0.111; TCGA KIRC -0.106; TCGA LGG -0.226; TCGA LUAD -0.052; TCGA LUSC -0.144; TCGA PAAD -0.16; TCGA PRAD -0.068; TCGA SARC -0.233; TCGA UCEC -0.066 |
hsa-miR-338-3p | DOCK9 | 9 cancers: BLCA; CESC; ESCA; HNSC; OV; PAAD; PRAD; THCA; STAD | miRanda | TCGA BLCA -0.099; TCGA CESC -0.11; TCGA ESCA -0.114; TCGA HNSC -0.111; TCGA OV -0.088; TCGA PAAD -0.113; TCGA PRAD -0.105; TCGA THCA -0.221; TCGA STAD -0.091 |
hsa-miR-338-3p | PPM1L | 10 cancers: BLCA; BRCA; CESC; HNSC; LIHC; LUSC; PAAD; PRAD; SARC; UCEC | miRanda | TCGA BLCA -0.24; TCGA BRCA -0.083; TCGA CESC -0.212; TCGA HNSC -0.307; TCGA LIHC -0.197; TCGA LUSC -0.135; TCGA PAAD -0.154; TCGA PRAD -0.294; TCGA SARC -0.322; TCGA UCEC -0.14 |
hsa-miR-338-3p | USP31 | 11 cancers: BLCA; CESC; ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; SARC; THCA; STAD | miRanda | TCGA BLCA -0.137; TCGA CESC -0.205; TCGA ESCA -0.256; TCGA HNSC -0.066; TCGA LIHC -0.072; TCGA LUAD -0.068; TCGA LUSC -0.216; TCGA PAAD -0.07; TCGA SARC -0.126; TCGA THCA -0.209; TCGA STAD -0.069 |
hsa-miR-338-3p | MARCKS | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; STAD | miRanda | TCGA BLCA -0.074; TCGA BRCA -0.058; TCGA CESC -0.173; TCGA COAD -0.106; TCGA ESCA -0.216; TCGA HNSC -0.055; TCGA KIRP -0.155; TCGA LGG -0.101; TCGA LUAD -0.123; TCGA LUSC -0.141; TCGA STAD -0.107 |
hsa-miR-338-3p | RSBN1L | 9 cancers: BLCA; CESC; COAD; HNSC; KIRP; LGG; LUSC; PRAD; SARC | miRanda | TCGA BLCA -0.091; TCGA CESC -0.05; TCGA COAD -0.061; TCGA HNSC -0.151; TCGA KIRP -0.111; TCGA LGG -0.064; TCGA LUSC -0.066; TCGA PRAD -0.122; TCGA SARC -0.158 |
hsa-miR-338-3p | STRN | 11 cancers: BLCA; BRCA; COAD; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA | miRanda | TCGA BLCA -0.09; TCGA BRCA -0.122; TCGA COAD -0.084; TCGA HNSC -0.274; TCGA LIHC -0.122; TCGA LUAD -0.124; TCGA LUSC -0.13; TCGA PAAD -0.242; TCGA PRAD -0.366; TCGA SARC -0.091; TCGA THCA -0.321 |
hsa-miR-338-3p | AR | 9 cancers: BLCA; BRCA; HNSC; KIRP; LGG; LIHC; PRAD; SARC; STAD | miRanda | TCGA BLCA -0.477; TCGA BRCA -0.145; TCGA HNSC -0.427; TCGA KIRP -0.389; TCGA LGG -0.233; TCGA LIHC -0.729; TCGA PRAD -0.386; TCGA SARC -0.757; TCGA STAD -0.347 |
hsa-miR-338-3p | RB1CC1 | 11 cancers: BLCA; CESC; COAD; HNSC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA | miRanda | TCGA BLCA -0.094; TCGA CESC -0.059; TCGA COAD -0.07; TCGA HNSC -0.127; TCGA LUAD -0.08; TCGA LUSC -0.064; TCGA OV -0.058; TCGA PAAD -0.098; TCGA PRAD -0.131; TCGA SARC -0.092; TCGA THCA -0.066 |
hsa-miR-338-3p | ZHX1 | 9 cancers: BLCA; CESC; HNSC; LGG; LUAD; OV; PRAD; SARC; THCA | miRanda | TCGA BLCA -0.105; TCGA CESC -0.139; TCGA HNSC -0.069; TCGA LGG -0.069; TCGA LUAD -0.056; TCGA OV -0.068; TCGA PRAD -0.122; TCGA SARC -0.121; TCGA THCA -0.058 |
hsa-miR-338-3p | LCA5 | 9 cancers: BLCA; BRCA; COAD; HNSC; KIRP; PRAD; SARC; THCA; STAD | miRanda | TCGA BLCA -0.169; TCGA BRCA -0.12; TCGA COAD -0.215; TCGA HNSC -0.216; TCGA KIRP -0.107; TCGA PRAD -0.124; TCGA SARC -0.232; TCGA THCA -0.062; TCGA STAD -0.148 |
hsa-miR-338-3p | SP4 | 9 cancers: BLCA; CESC; COAD; HNSC; LGG; LUAD; PRAD; SARC; STAD | miRanda | TCGA BLCA -0.077; TCGA CESC -0.082; TCGA COAD -0.14; TCGA HNSC -0.241; TCGA LGG -0.097; TCGA LUAD -0.12; TCGA PRAD -0.179; TCGA SARC -0.146; TCGA STAD -0.074 |
hsa-miR-338-3p | ATL1 | 11 cancers: BLCA; BRCA; CESC; COAD; HNSC; LUAD; PRAD; SARC; THCA; STAD; UCEC | miRanda | TCGA BLCA -0.122; TCGA BRCA -0.069; TCGA CESC -0.135; TCGA COAD -0.14; TCGA HNSC -0.096; TCGA LUAD -0.105; TCGA PRAD -0.106; TCGA SARC -0.276; TCGA THCA -0.089; TCGA STAD -0.083; TCGA UCEC -0.063 |
hsa-miR-338-3p | SCYL2 | 12 cancers: BLCA; BRCA; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA | miRanda | TCGA BLCA -0.09; TCGA BRCA -0.069; TCGA HNSC -0.176; TCGA KIRC -0.199; TCGA LGG -0.083; TCGA LIHC -0.075; TCGA LUAD -0.074; TCGA LUSC -0.088; TCGA PAAD -0.099; TCGA PRAD -0.184; TCGA SARC -0.065; TCGA THCA -0.125 |
hsa-miR-338-3p | TECPR2 | 9 cancers: BLCA; ESCA; HNSC; KIRP; LIHC; PRAD; SARC; THCA; STAD | miRanda | TCGA BLCA -0.094; TCGA ESCA -0.059; TCGA HNSC -0.077; TCGA KIRP -0.089; TCGA LIHC -0.07; TCGA PRAD -0.051; TCGA SARC -0.097; TCGA THCA -0.053; TCGA STAD -0.11 |
hsa-miR-338-3p | FBXO30 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PRAD; SARC | miRanda | TCGA BLCA -0.074; TCGA BRCA -0.085; TCGA CESC -0.072; TCGA COAD -0.086; TCGA ESCA -0.117; TCGA HNSC -0.108; TCGA LGG -0.14; TCGA LUAD -0.081; TCGA LUSC -0.104; TCGA PRAD -0.06; TCGA SARC -0.266 |
hsa-miR-338-3p | IQCH | 9 cancers: BLCA; HNSC; KIRC; KIRP; LGG; LIHC; PRAD; STAD; UCEC | miRanda | TCGA BLCA -0.108; TCGA HNSC -0.154; TCGA KIRC -0.39; TCGA KIRP -0.259; TCGA LGG -0.108; TCGA LIHC -0.377; TCGA PRAD -0.1; TCGA STAD -0.095; TCGA UCEC -0.125 |
hsa-miR-338-3p | PAWR | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; SARC; THCA | miRanda | TCGA BLCA -0.119; TCGA BRCA -0.052; TCGA CESC -0.119; TCGA ESCA -0.188; TCGA HNSC -0.126; TCGA KIRC -0.193; TCGA LUAD -0.072; TCGA LUSC -0.158; TCGA PAAD -0.171; TCGA PRAD -0.144; TCGA SARC -0.487; TCGA THCA -0.139 |
hsa-miR-338-3p | PBX1 | 9 cancers: BLCA; CESC; COAD; HNSC; LGG; LUSC; PRAD; SARC; STAD | miRanda | TCGA BLCA -0.214; TCGA CESC -0.146; TCGA COAD -0.167; TCGA HNSC -0.219; TCGA LGG -0.068; TCGA LUSC -0.086; TCGA PRAD -0.121; TCGA SARC -0.504; TCGA STAD -0.23 |
hsa-miR-338-3p | KDM5B | 10 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LGG; LUSC; PAAD; PRAD; THCA | miRanda | TCGA BLCA -0.131; TCGA BRCA -0.103; TCGA ESCA -0.17; TCGA HNSC -0.129; TCGA KIRP -0.058; TCGA LGG -0.108; TCGA LUSC -0.221; TCGA PAAD -0.158; TCGA PRAD -0.103; TCGA THCA -0.115 |
hsa-miR-338-3p | FAM160A1 | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; THCA | miRanda | TCGA BLCA -0.149; TCGA BRCA -0.094; TCGA CESC -0.116; TCGA ESCA -0.166; TCGA HNSC -0.15; TCGA KIRC -0.183; TCGA LUAD -0.081; TCGA LUSC -0.151; TCGA PAAD -0.318; TCGA PRAD -0.24; TCGA THCA -0.156 |
hsa-miR-338-3p | SDC1 | 10 cancers: BLCA; BRCA; CESC; ESCA; KIRC; LGG; LIHC; LUSC; PAAD; THCA | miRanda | TCGA BLCA -0.184; TCGA BRCA -0.214; TCGA CESC -0.214; TCGA ESCA -0.512; TCGA KIRC -0.324; TCGA LGG -0.146; TCGA LIHC -0.156; TCGA LUSC -0.251; TCGA PAAD -0.348; TCGA THCA -0.221 |
hsa-miR-338-3p | HHAT | 9 cancers: BLCA; CESC; ESCA; HNSC; KIRC; KIRP; LIHC; LUSC; PAAD | miRanda | TCGA BLCA -0.152; TCGA CESC -0.157; TCGA ESCA -0.19; TCGA HNSC -0.187; TCGA KIRC -0.132; TCGA KIRP -0.185; TCGA LIHC -0.153; TCGA LUSC -0.128; TCGA PAAD -0.125 |
hsa-miR-338-3p | HIVEP2 | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LIHC; LUAD; PAAD; PRAD; THCA; STAD | miRanda | TCGA BLCA -0.136; TCGA BRCA -0.125; TCGA CESC -0.072; TCGA ESCA -0.103; TCGA HNSC -0.167; TCGA KIRP -0.09; TCGA LIHC -0.096; TCGA LUAD -0.088; TCGA PAAD -0.154; TCGA PRAD -0.114; TCGA THCA -0.145; TCGA STAD -0.086 |
hsa-miR-338-3p | L3MBTL3 | 9 cancers: BLCA; COAD; HNSC; KIRP; LUAD; PAAD; PRAD; STAD; UCEC | miRanda | TCGA BLCA -0.113; TCGA COAD -0.11; TCGA HNSC -0.069; TCGA KIRP -0.139; TCGA LUAD -0.081; TCGA PAAD -0.178; TCGA PRAD -0.066; TCGA STAD -0.095; TCGA UCEC -0.076 |
hsa-miR-338-3p | ZNF658 | 9 cancers: BLCA; CESC; COAD; ESCA; LGG; LIHC; PRAD; SARC; UCEC | miRanda | TCGA BLCA -0.151; TCGA CESC -0.172; TCGA COAD -0.095; TCGA ESCA -0.21; TCGA LGG -0.066; TCGA LIHC -0.088; TCGA PRAD -0.051; TCGA SARC -0.21; TCGA UCEC -0.089 |
hsa-miR-338-3p | RPRM | 9 cancers: BLCA; CESC; COAD; ESCA; KIRC; LUSC; SARC; STAD; UCEC | miRanda | TCGA BLCA -0.367; TCGA CESC -0.281; TCGA COAD -0.362; TCGA ESCA -0.546; TCGA KIRC -0.916; TCGA LUSC -0.383; TCGA SARC -0.576; TCGA STAD -0.45; TCGA UCEC -0.234 |
hsa-miR-338-3p | MPPED2 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LUSC; OV; PRAD; STAD; UCEC | miRanda | TCGA BLCA -0.323; TCGA BRCA -0.103; TCGA CESC -0.426; TCGA COAD -0.277; TCGA ESCA -0.509; TCGA KIRC -0.357; TCGA LUSC -0.217; TCGA OV -0.138; TCGA PRAD -0.125; TCGA STAD -0.334; TCGA UCEC -0.224 |
hsa-miR-338-3p | ANKIB1 | 9 cancers: BLCA; COAD; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA | miRanda | TCGA BLCA -0.084; TCGA COAD -0.062; TCGA HNSC -0.156; TCGA KIRP -0.138; TCGA LUAD -0.101; TCGA LUSC -0.082; TCGA PAAD -0.108; TCGA PRAD -0.15; TCGA THCA -0.064 |
hsa-miR-338-3p | BAZ1A | 13 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | miRanda | TCGA BLCA -0.095; TCGA BRCA -0.1; TCGA CESC -0.144; TCGA ESCA -0.149; TCGA HNSC -0.127; TCGA KIRP -0.158; TCGA LGG -0.158; TCGA LUAD -0.083; TCGA LUSC -0.082; TCGA PAAD -0.242; TCGA PRAD -0.09; TCGA THCA -0.133; TCGA UCEC -0.088 |
hsa-miR-338-3p | CPNE3 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; OV; PAAD; PRAD; THCA | miRanda | TCGA BLCA -0.115; TCGA CESC -0.106; TCGA COAD -0.075; TCGA ESCA -0.076; TCGA HNSC -0.103; TCGA KIRC -0.107; TCGA LGG -0.124; TCGA LUAD -0.054; TCGA OV -0.093; TCGA PAAD -0.069; TCGA PRAD -0.167; TCGA THCA -0.103 |
hsa-miR-338-3p | RBBP5 | 9 cancers: BLCA; BRCA; HNSC; KIRC; LUSC; PAAD; PRAD; SARC; THCA | miRanda | TCGA BLCA -0.081; TCGA BRCA -0.058; TCGA HNSC -0.226; TCGA KIRC -0.086; TCGA LUSC -0.129; TCGA PAAD -0.079; TCGA PRAD -0.179; TCGA SARC -0.127; TCGA THCA -0.128 |
hsa-miR-338-3p | GNG12 | 13 cancers: BLCA; BRCA; CESC; HNSC; KIRP; LGG; LIHC; LUAD; PAAD; PRAD; SARC; THCA; UCEC | miRanda | TCGA BLCA -0.074; TCGA BRCA -0.096; TCGA CESC -0.095; TCGA HNSC -0.085; TCGA KIRP -0.054; TCGA LGG -0.105; TCGA LIHC -0.149; TCGA LUAD -0.077; TCGA PAAD -0.158; TCGA PRAD -0.116; TCGA SARC -0.158; TCGA THCA -0.123; TCGA UCEC -0.102 |
hsa-miR-338-3p | TP63 | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LIHC; LUSC; PAAD; THCA; STAD | miRanda | TCGA BLCA -0.395; TCGA BRCA -0.292; TCGA CESC -1.08; TCGA ESCA -2.232; TCGA HNSC -0.253; TCGA LGG -0.102; TCGA LIHC -0.224; TCGA LUSC -0.837; TCGA PAAD -0.495; TCGA THCA -0.504; TCGA STAD -0.267 |
hsa-miR-338-3p | ZNF292 | 10 cancers: BLCA; BRCA; HNSC; KIRP; LGG; LUAD; LUSC; PRAD; SARC; THCA | miRanda | TCGA BLCA -0.19; TCGA BRCA -0.087; TCGA HNSC -0.188; TCGA KIRP -0.083; TCGA LGG -0.056; TCGA LUAD -0.062; TCGA LUSC -0.098; TCGA PRAD -0.111; TCGA SARC -0.133; TCGA THCA -0.069 |
hsa-miR-338-3p | DENND4C | 9 cancers: BLCA; HNSC; KIRP; LGG; LIHC; OV; PRAD; SARC; THCA | miRanda | TCGA BLCA -0.098; TCGA HNSC -0.082; TCGA KIRP -0.094; TCGA LGG -0.06; TCGA LIHC -0.106; TCGA OV -0.069; TCGA PRAD -0.132; TCGA SARC -0.147; TCGA THCA -0.076 |
hsa-miR-338-3p | DLX5 | 9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUAD; LUSC; STAD; UCEC | miRanda | TCGA BLCA -0.246; TCGA BRCA -0.159; TCGA CESC -0.488; TCGA ESCA -1.397; TCGA HNSC -0.259; TCGA LUAD -0.33; TCGA LUSC -0.88; TCGA STAD -0.315; TCGA UCEC -0.348 |
hsa-miR-338-3p | AHNAK | 9 cancers: BLCA; CESC; ESCA; HNSC; KIRP; PAAD; PRAD; SARC; THCA | miRanda | TCGA BLCA -0.129; TCGA CESC -0.131; TCGA ESCA -0.112; TCGA HNSC -0.148; TCGA KIRP -0.193; TCGA PAAD -0.278; TCGA PRAD -0.171; TCGA SARC -0.068; TCGA THCA -0.233 |
hsa-miR-338-3p | UHMK1 | 9 cancers: BLCA; BRCA; HNSC; KIRC; LIHC; LUSC; PAAD; PRAD; THCA | miRanda | TCGA BLCA -0.148; TCGA BRCA -0.108; TCGA HNSC -0.453; TCGA KIRC -0.212; TCGA LIHC -0.206; TCGA LUSC -0.109; TCGA PAAD -0.242; TCGA PRAD -0.44; TCGA THCA -0.403 |
hsa-miR-338-3p | NPTXR | 12 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; SARC; THCA; STAD | miRanda | TCGA BLCA -0.232; TCGA COAD -0.264; TCGA ESCA -0.231; TCGA HNSC -0.163; TCGA KIRC -0.372; TCGA KIRP -0.174; TCGA LUAD -0.083; TCGA LUSC -0.147; TCGA PRAD -0.057; TCGA SARC -0.142; TCGA THCA -0.276; TCGA STAD -0.421 |
hsa-miR-338-3p | TMTC3 | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; PRAD; THCA | miRanda | TCGA BLCA -0.142; TCGA BRCA -0.054; TCGA CESC -0.161; TCGA ESCA -0.405; TCGA HNSC -0.215; TCGA KIRP -0.051; TCGA LIHC -0.066; TCGA LUAD -0.113; TCGA LUSC -0.272; TCGA PRAD -0.153; TCGA THCA -0.084 |
hsa-miR-338-3p | NFE2L2 | 11 cancers: BLCA; CESC; ESCA; HNSC; KIRC; LGG; LIHC; LUSC; PAAD; PRAD; SARC | miRanda | TCGA BLCA -0.105; TCGA CESC -0.194; TCGA ESCA -0.225; TCGA HNSC -0.147; TCGA KIRC -0.098; TCGA LGG -0.051; TCGA LIHC -0.137; TCGA LUSC -0.152; TCGA PAAD -0.125; TCGA PRAD -0.076; TCGA SARC -0.094 |
hsa-miR-338-3p | BRD3 | 10 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LGG; LUSC; PRAD; SARC; STAD | miRanda | TCGA BLCA -0.071; TCGA BRCA -0.067; TCGA ESCA -0.07; TCGA HNSC -0.172; TCGA KIRP -0.161; TCGA LGG -0.054; TCGA LUSC -0.103; TCGA PRAD -0.085; TCGA SARC -0.095; TCGA STAD -0.088 |
hsa-miR-338-3p | EPM2AIP1 | 9 cancers: BLCA; COAD; HNSC; KIRC; KIRP; LIHC; PRAD; SARC; STAD | miRanda | TCGA BLCA -0.14; TCGA COAD -0.186; TCGA HNSC -0.055; TCGA KIRC -0.127; TCGA KIRP -0.084; TCGA LIHC -0.083; TCGA PRAD -0.076; TCGA SARC -0.184; TCGA STAD -0.165 |
hsa-miR-338-3p | CYP27C1 | 9 cancers: BLCA; BRCA; CESC; ESCA; KIRP; LUAD; LUSC; PAAD; STAD | miRanda | TCGA BLCA -0.193; TCGA BRCA -0.301; TCGA CESC -0.495; TCGA ESCA -1.101; TCGA KIRP -0.711; TCGA LUAD -0.165; TCGA LUSC -0.276; TCGA PAAD -0.491; TCGA STAD -0.159 |
hsa-miR-338-3p | BHLHE41 | 9 cancers: BLCA; BRCA; HNSC; KIRP; LUAD; OV; PAAD; PRAD; THCA | miRanda | TCGA BLCA -0.165; TCGA BRCA -0.188; TCGA HNSC -0.179; TCGA KIRP -0.15; TCGA LUAD -0.11; TCGA OV -0.224; TCGA PAAD -0.252; TCGA PRAD -0.075; TCGA THCA -0.145 |
hsa-miR-338-3p | ANTXR1 | 12 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; OV; PAAD; STAD; UCEC | miRanda | TCGA BLCA -0.097; TCGA BRCA -0.227; TCGA ESCA -0.372; TCGA HNSC -0.304; TCGA KIRP -0.169; TCGA LGG -0.167; TCGA LUAD -0.175; TCGA LUSC -0.112; TCGA OV -0.112; TCGA PAAD -0.333; TCGA STAD -0.221; TCGA UCEC -0.127 |
hsa-miR-338-3p | PHF2 | 10 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LGG; PRAD; SARC; STAD; UCEC | miRanda | TCGA BLCA -0.072; TCGA CESC -0.052; TCGA ESCA -0.083; TCGA HNSC -0.135; TCGA KIRP -0.085; TCGA LGG -0.059; TCGA PRAD -0.059; TCGA SARC -0.109; TCGA STAD -0.115; TCGA UCEC -0.071 |
hsa-miR-338-3p | GALNT1 | 10 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LGG; LUSC; PAAD; PRAD; THCA | miRanda | TCGA BLCA -0.14; TCGA BRCA -0.086; TCGA ESCA -0.16; TCGA HNSC -0.073; TCGA KIRP -0.107; TCGA LGG -0.092; TCGA LUSC -0.151; TCGA PAAD -0.18; TCGA PRAD -0.126; TCGA THCA -0.177 |
hsa-miR-338-3p | ATP9A | 9 cancers: BLCA; HNSC; KIRC; KIRP; LUAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.133; TCGA HNSC -0.166; TCGA KIRC -0.363; TCGA KIRP -0.161; TCGA LUAD -0.076; TCGA PRAD -0.14; TCGA SARC -0.245; TCGA THCA -0.075; TCGA STAD -0.084 |
hsa-miR-338-3p | SUN2 | 10 cancers: BLCA; CESC; ESCA; HNSC; LIHC; OV; PAAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.065; TCGA CESC -0.111; TCGA ESCA -0.146; TCGA HNSC -0.077; TCGA LIHC -0.117; TCGA OV -0.063; TCGA PAAD -0.083; TCGA SARC -0.142; TCGA THCA -0.156; TCGA STAD -0.12 |
hsa-miR-338-3p | BBX | 11 cancers: BLCA; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PRAD; SARC; THCA | mirMAP; miRNATAP | TCGA BLCA -0.102; TCGA COAD -0.071; TCGA HNSC -0.217; TCGA KIRC -0.129; TCGA KIRP -0.077; TCGA LIHC -0.111; TCGA LUAD -0.074; TCGA LUSC -0.052; TCGA PRAD -0.14; TCGA SARC -0.114; TCGA THCA -0.063 |
hsa-miR-338-3p | ATXN1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.123; TCGA BRCA -0.113; TCGA CESC -0.109; TCGA COAD -0.092; TCGA ESCA -0.14; TCGA HNSC -0.16; TCGA LIHC -0.114; TCGA LUAD -0.076; TCGA PAAD -0.179; TCGA SARC -0.067; TCGA STAD -0.131; TCGA UCEC -0.146 |
hsa-miR-338-3p | VPS13B | 10 cancers: BLCA; CESC; COAD; HNSC; LGG; OV; PAAD; PRAD; SARC; THCA | mirMAP | TCGA BLCA -0.106; TCGA CESC -0.061; TCGA COAD -0.084; TCGA HNSC -0.197; TCGA LGG -0.06; TCGA OV -0.083; TCGA PAAD -0.095; TCGA PRAD -0.192; TCGA SARC -0.12; TCGA THCA -0.079 |
hsa-miR-338-3p | BNIP2 | 10 cancers: BLCA; BRCA; CESC; ESCA; KIRP; LGG; LIHC; PAAD; SARC; STAD | mirMAP | TCGA BLCA -0.073; TCGA BRCA -0.058; TCGA CESC -0.074; TCGA ESCA -0.136; TCGA KIRP -0.053; TCGA LGG -0.089; TCGA LIHC -0.057; TCGA PAAD -0.137; TCGA SARC -0.075; TCGA STAD -0.057 |
hsa-miR-338-3p | PSD3 | 14 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.178; TCGA BRCA -0.234; TCGA CESC -0.213; TCGA HNSC -0.267; TCGA KIRC -0.41; TCGA KIRP -0.172; TCGA LIHC -0.24; TCGA LUAD -0.064; TCGA LUSC -0.185; TCGA PAAD -0.22; TCGA PRAD -0.152; TCGA THCA -0.142; TCGA STAD -0.095; TCGA UCEC -0.117 |
hsa-miR-338-3p | TMEM154 | 11 cancers: BLCA; BRCA; CESC; ESCA; LGG; LUSC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.212; TCGA BRCA -0.072; TCGA CESC -0.311; TCGA ESCA -0.621; TCGA LGG -0.09; TCGA LUSC -0.102; TCGA PAAD -0.242; TCGA PRAD -0.128; TCGA THCA -0.138; TCGA STAD -0.133; TCGA UCEC -0.202 |
hsa-miR-338-3p | SH3PXD2A | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUSC; PAAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.147; TCGA BRCA -0.134; TCGA CESC -0.084; TCGA ESCA -0.191; TCGA HNSC -0.08; TCGA LUSC -0.138; TCGA PAAD -0.186; TCGA THCA -0.077; TCGA STAD -0.118; TCGA UCEC -0.064 |
hsa-miR-338-3p | MAP3K2 | 11 cancers: BLCA; BRCA; HNSC; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA | miRNATAP | TCGA BLCA -0.102; TCGA BRCA -0.061; TCGA HNSC -0.289; TCGA LGG -0.074; TCGA LIHC -0.136; TCGA LUAD -0.071; TCGA LUSC -0.062; TCGA PAAD -0.187; TCGA PRAD -0.175; TCGA SARC -0.096; TCGA THCA -0.217 |
hsa-miR-338-3p | ARHGAP32 | 9 cancers: BLCA; BRCA; KIRP; LIHC; LUSC; PAAD; PRAD; THCA; UCEC | miRNATAP | TCGA BLCA -0.176; TCGA BRCA -0.061; TCGA KIRP -0.067; TCGA LIHC -0.103; TCGA LUSC -0.095; TCGA PAAD -0.167; TCGA PRAD -0.178; TCGA THCA -0.196; TCGA UCEC -0.1 |
hsa-miR-338-3p | SOX4 | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | miRNATAP | TCGA BLCA -0.138; TCGA BRCA -0.156; TCGA COAD -0.114; TCGA ESCA -0.205; TCGA HNSC -0.214; TCGA KIRC -0.099; TCGA KIRP -0.328; TCGA LGG -0.198; TCGA LUAD -0.081; TCGA LUSC -0.319; TCGA PAAD -0.31; TCGA PRAD -0.127; TCGA THCA -0.337; TCGA UCEC -0.115 |
hsa-miR-338-3p | MMP2 | 10 cancers: BRCA; ESCA; HNSC; LGG; LUAD; OV; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.244; TCGA ESCA -0.304; TCGA HNSC -0.192; TCGA LGG -0.202; TCGA LUAD -0.086; TCGA OV -0.191; TCGA PAAD -0.584; TCGA THCA -0.126; TCGA STAD -0.148; TCGA UCEC -0.307 |
hsa-miR-338-3p | RUNX2 | 9 cancers: BRCA; ESCA; LUAD; LUSC; OV; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate; PITA; miRanda; miRNATAP | TCGA BRCA -0.175; TCGA ESCA -0.327; TCGA LUAD -0.113; TCGA LUSC -0.213; TCGA OV -0.147; TCGA PAAD -0.46; TCGA THCA -0.408; TCGA STAD -0.091; TCGA UCEC -0.137 |
hsa-miR-338-3p | THBS1 | 10 cancers: BRCA; HNSC; LGG; LUAD; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; PITA; miRanda | TCGA BRCA -0.085; TCGA HNSC -0.132; TCGA LGG -0.218; TCGA LUAD -0.137; TCGA OV -0.168; TCGA PAAD -0.349; TCGA PRAD -0.179; TCGA THCA -0.403; TCGA STAD -0.201; TCGA UCEC -0.242 |
hsa-miR-338-3p | ATP10D | 12 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LIHC; LUAD; PAAD; PRAD; STAD | MirTarget; miRanda | TCGA BRCA -0.093; TCGA CESC -0.193; TCGA COAD -0.106; TCGA ESCA -0.355; TCGA HNSC -0.139; TCGA KIRC -0.088; TCGA LGG -0.114; TCGA LIHC -0.114; TCGA LUAD -0.084; TCGA PAAD -0.108; TCGA PRAD -0.141; TCGA STAD -0.067 |
hsa-miR-338-3p | SOX6 | 10 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; PRAD; SARC | MirTarget; miRNATAP | TCGA BRCA -0.256; TCGA COAD -0.242; TCGA HNSC -0.197; TCGA KIRC -0.199; TCGA KIRP -0.118; TCGA LGG -0.134; TCGA LIHC -0.257; TCGA LUSC -0.268; TCGA PRAD -0.078; TCGA SARC -0.191 |
hsa-miR-338-3p | ZFHX4 | 13 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; OV; PAAD; THCA; STAD | MirTarget; PITA; miRanda; miRNATAP | TCGA BRCA -0.256; TCGA CESC -0.242; TCGA COAD -0.304; TCGA ESCA -0.679; TCGA HNSC -0.284; TCGA KIRC -0.537; TCGA LIHC -0.23; TCGA LUAD -0.175; TCGA LUSC -0.452; TCGA OV -0.215; TCGA PAAD -0.27; TCGA THCA -0.146; TCGA STAD -0.274 |
hsa-miR-338-3p | ABCA12 | 9 cancers: BRCA; CESC; ESCA; HNSC; KIRP; LUSC; PAAD; THCA; UCEC | MirTarget; miRanda | TCGA BRCA -0.257; TCGA CESC -0.322; TCGA ESCA -0.796; TCGA HNSC -0.253; TCGA KIRP -0.268; TCGA LUSC -0.975; TCGA PAAD -0.517; TCGA THCA -0.943; TCGA UCEC -0.292 |
hsa-miR-338-3p | CYP2U1 | 9 cancers: BRCA; CESC; KIRC; LGG; LIHC; LUAD; PRAD; SARC; STAD | MirTarget | TCGA BRCA -0.053; TCGA CESC -0.107; TCGA KIRC -0.119; TCGA LGG -0.101; TCGA LIHC -0.296; TCGA LUAD -0.054; TCGA PRAD -0.157; TCGA SARC -0.092; TCGA STAD -0.161 |
hsa-miR-338-3p | LEPROT | 9 cancers: BRCA; COAD; HNSC; LGG; LIHC; PAAD; PRAD; THCA; STAD | MirTarget; PITA; miRanda | TCGA BRCA -0.096; TCGA COAD -0.097; TCGA HNSC -0.264; TCGA LGG -0.078; TCGA LIHC -0.175; TCGA PAAD -0.283; TCGA PRAD -0.238; TCGA THCA -0.267; TCGA STAD -0.059 |
hsa-miR-338-3p | ABI1 | 9 cancers: BRCA; CESC; ESCA; HNSC; LUSC; OV; PAAD; PRAD; THCA | MirTarget; PITA; miRanda | TCGA BRCA -0.052; TCGA CESC -0.126; TCGA ESCA -0.097; TCGA HNSC -0.057; TCGA LUSC -0.08; TCGA OV -0.05; TCGA PAAD -0.065; TCGA PRAD -0.087; TCGA THCA -0.116 |
hsa-miR-338-3p | LAMC1 | 10 cancers: BRCA; COAD; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; THCA; STAD | MirTarget; miRanda | TCGA BRCA -0.109; TCGA COAD -0.123; TCGA HNSC -0.213; TCGA KIRP -0.18; TCGA LGG -0.235; TCGA LUAD -0.063; TCGA LUSC -0.12; TCGA PAAD -0.208; TCGA THCA -0.084; TCGA STAD -0.187 |
hsa-miR-338-3p | HIF1A | 10 cancers: BRCA; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; PAAD; PRAD; THCA | MirTarget; PITA; miRanda | TCGA BRCA -0.147; TCGA ESCA -0.182; TCGA HNSC -0.19; TCGA KIRC -0.334; TCGA LGG -0.169; TCGA LUAD -0.086; TCGA LUSC -0.128; TCGA PAAD -0.182; TCGA PRAD -0.156; TCGA THCA -0.236 |
hsa-miR-338-3p | MAF | 9 cancers: BRCA; CESC; ESCA; HNSC; LIHC; LUSC; PAAD; STAD; UCEC | PITA; miRanda; miRNATAP | TCGA BRCA -0.068; TCGA CESC -0.448; TCGA ESCA -0.597; TCGA HNSC -0.117; TCGA LIHC -0.131; TCGA LUSC -0.099; TCGA PAAD -0.162; TCGA STAD -0.117; TCGA UCEC -0.119 |
hsa-miR-338-3p | NPAT | 10 cancers: BRCA; CESC; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA | PITA; miRanda | TCGA BRCA -0.092; TCGA CESC -0.057; TCGA HNSC -0.15; TCGA LGG -0.072; TCGA LUAD -0.059; TCGA LUSC -0.052; TCGA PAAD -0.117; TCGA PRAD -0.151; TCGA SARC -0.161; TCGA THCA -0.128 |
hsa-miR-338-3p | ADAM17 | 9 cancers: BRCA; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; THCA | PITA; miRanda; miRNATAP | TCGA BRCA -0.085; TCGA ESCA -0.314; TCGA HNSC -0.268; TCGA LGG -0.122; TCGA LUAD -0.096; TCGA LUSC -0.117; TCGA PAAD -0.202; TCGA PRAD -0.13; TCGA THCA -0.091 |
hsa-miR-338-3p | GLIPR1 | 9 cancers: BRCA; CESC; ESCA; OV; PAAD; SARC; THCA; STAD; UCEC | PITA; miRanda | TCGA BRCA -0.132; TCGA CESC -0.106; TCGA ESCA -0.203; TCGA OV -0.08; TCGA PAAD -0.221; TCGA SARC -0.158; TCGA THCA -0.167; TCGA STAD -0.098; TCGA UCEC -0.087 |
hsa-miR-338-3p | BACH2 | 9 cancers: BRCA; CESC; ESCA; HNSC; LIHC; LUAD; LUSC; THCA; STAD | PITA | TCGA BRCA -0.314; TCGA CESC -0.341; TCGA ESCA -0.448; TCGA HNSC -0.153; TCGA LIHC -0.268; TCGA LUAD -0.126; TCGA LUSC -0.097; TCGA THCA -0.215; TCGA STAD -0.195 |
hsa-miR-338-3p | STYX | 9 cancers: BRCA; CESC; COAD; ESCA; LGG; LUAD; PAAD; PRAD; THCA | miRanda; miRNATAP | TCGA BRCA -0.079; TCGA CESC -0.096; TCGA COAD -0.063; TCGA ESCA -0.142; TCGA LGG -0.051; TCGA LUAD -0.102; TCGA PAAD -0.08; TCGA PRAD -0.101; TCGA THCA -0.102 |
hsa-miR-338-3p | ARL4C | 9 cancers: BRCA; CESC; ESCA; HNSC; KIRP; LUAD; LUSC; THCA; STAD | miRanda | TCGA BRCA -0.179; TCGA CESC -0.151; TCGA ESCA -0.556; TCGA HNSC -0.098; TCGA KIRP -0.315; TCGA LUAD -0.068; TCGA LUSC -0.144; TCGA THCA -0.454; TCGA STAD -0.213 |
hsa-miR-338-3p | ZNF765 | 9 cancers: BRCA; HNSC; KIRP; LGG; LUAD; LUSC; PRAD; SARC; THCA | miRanda | TCGA BRCA -0.065; TCGA HNSC -0.115; TCGA KIRP -0.051; TCGA LGG -0.092; TCGA LUAD -0.071; TCGA LUSC -0.053; TCGA PRAD -0.058; TCGA SARC -0.051; TCGA THCA -0.083 |
hsa-miR-338-3p | PDE1A | 9 cancers: BRCA; COAD; KIRC; OV; PRAD; SARC; THCA; STAD; UCEC | miRanda | TCGA BRCA -0.127; TCGA COAD -0.277; TCGA KIRC -0.596; TCGA OV -0.258; TCGA PRAD -0.164; TCGA SARC -0.313; TCGA THCA -0.132; TCGA STAD -0.25; TCGA UCEC -0.101 |
hsa-miR-338-3p | ARL13B | 11 cancers: BRCA; CESC; ESCA; HNSC; KIRP; LGG; LIHC; PAAD; PRAD; SARC; THCA | miRanda | TCGA BRCA -0.055; TCGA CESC -0.119; TCGA ESCA -0.097; TCGA HNSC -0.223; TCGA KIRP -0.135; TCGA LGG -0.073; TCGA LIHC -0.081; TCGA PAAD -0.106; TCGA PRAD -0.106; TCGA SARC -0.101; TCGA THCA -0.178 |
hsa-miR-338-3p | CALD1 | 13 cancers: BRCA; COAD; ESCA; HNSC; LGG; LIHC; LUAD; OV; PAAD; SARC; THCA; STAD; UCEC | miRanda | TCGA BRCA -0.182; TCGA COAD -0.223; TCGA ESCA -0.245; TCGA HNSC -0.17; TCGA LGG -0.155; TCGA LIHC -0.103; TCGA LUAD -0.105; TCGA OV -0.084; TCGA PAAD -0.238; TCGA SARC -0.425; TCGA THCA -0.197; TCGA STAD -0.242; TCGA UCEC -0.156 |
hsa-miR-338-3p | PRIM2 | 9 cancers: BRCA; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; THCA | miRanda | TCGA BRCA -0.061; TCGA ESCA -0.132; TCGA HNSC -0.141; TCGA KIRP -0.073; TCGA LGG -0.149; TCGA LUAD -0.091; TCGA LUSC -0.224; TCGA PAAD -0.135; TCGA THCA -0.179 |
hsa-miR-338-3p | DOCK11 | 11 cancers: BRCA; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; PAAD; PRAD; THCA; STAD | miRanda | TCGA BRCA -0.176; TCGA ESCA -0.134; TCGA HNSC -0.208; TCGA KIRC -0.133; TCGA KIRP -0.229; TCGA LGG -0.135; TCGA LUAD -0.096; TCGA PAAD -0.203; TCGA PRAD -0.08; TCGA THCA -0.177; TCGA STAD -0.17 |
hsa-miR-338-3p | CAV1 | 9 cancers: BRCA; CESC; COAD; ESCA; LGG; PAAD; SARC; THCA; STAD | miRanda | TCGA BRCA -0.087; TCGA CESC -0.214; TCGA COAD -0.208; TCGA ESCA -0.472; TCGA LGG -0.085; TCGA PAAD -0.309; TCGA SARC -0.187; TCGA THCA -0.251; TCGA STAD -0.19 |
hsa-miR-338-3p | TMPRSS13 | 9 cancers: BRCA; COAD; ESCA; KIRC; LUSC; PAAD; THCA; STAD; UCEC | miRanda | TCGA BRCA -0.191; TCGA COAD -0.329; TCGA ESCA -0.975; TCGA KIRC -0.528; TCGA LUSC -0.154; TCGA PAAD -0.317; TCGA THCA -0.391; TCGA STAD -0.351; TCGA UCEC -0.221 |
hsa-miR-338-3p | SP3 | 11 cancers: BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC | miRanda | TCGA BRCA -0.064; TCGA CESC -0.056; TCGA COAD -0.067; TCGA ESCA -0.109; TCGA HNSC -0.211; TCGA LGG -0.102; TCGA LUAD -0.058; TCGA LUSC -0.121; TCGA PAAD -0.126; TCGA PRAD -0.11; TCGA SARC -0.12 |
hsa-miR-338-3p | LRP12 | 10 cancers: BRCA; CESC; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PRAD; THCA | miRanda | TCGA BRCA -0.089; TCGA CESC -0.186; TCGA ESCA -0.728; TCGA HNSC -0.275; TCGA KIRC -0.1; TCGA LUAD -0.18; TCGA LUSC -0.291; TCGA OV -0.1; TCGA PRAD -0.162; TCGA THCA -0.113 |
hsa-miR-338-3p | TSLP | 9 cancers: BRCA; CESC; ESCA; KIRC; KIRP; LIHC; PAAD; THCA; STAD | miRanda | TCGA BRCA -0.158; TCGA CESC -0.604; TCGA ESCA -0.399; TCGA KIRC -0.396; TCGA KIRP -0.625; TCGA LIHC -0.381; TCGA PAAD -0.283; TCGA THCA -0.173; TCGA STAD -0.235 |
hsa-miR-338-3p | DYRK2 | 10 cancers: BRCA; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA | miRanda | TCGA BRCA -0.133; TCGA HNSC -0.137; TCGA KIRP -0.17; TCGA LGG -0.083; TCGA LUAD -0.084; TCGA LUSC -0.15; TCGA PAAD -0.131; TCGA PRAD -0.089; TCGA SARC -0.081; TCGA THCA -0.126 |
hsa-miR-338-3p | ITGB8 | 11 cancers: BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; THCA | miRanda | TCGA BRCA -0.132; TCGA COAD -0.248; TCGA ESCA -0.323; TCGA HNSC -0.276; TCGA KIRC -0.199; TCGA KIRP -0.516; TCGA LGG -0.119; TCGA LUAD -0.286; TCGA LUSC -0.398; TCGA PAAD -0.172; TCGA THCA -0.621 |
hsa-miR-338-3p | RAB23 | 14 cancers: BRCA; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRanda | TCGA BRCA -0.097; TCGA COAD -0.144; TCGA ESCA -0.17; TCGA HNSC -0.184; TCGA LGG -0.072; TCGA LIHC -0.063; TCGA LUAD -0.103; TCGA LUSC -0.065; TCGA PAAD -0.177; TCGA PRAD -0.105; TCGA SARC -0.431; TCGA THCA -0.193; TCGA STAD -0.186; TCGA UCEC -0.102 |
hsa-miR-338-3p | ATP11B | 9 cancers: BRCA; CESC; ESCA; HNSC; KIRP; LUSC; PAAD; PRAD; THCA | miRanda | TCGA BRCA -0.173; TCGA CESC -0.161; TCGA ESCA -0.147; TCGA HNSC -0.173; TCGA KIRP -0.071; TCGA LUSC -0.258; TCGA PAAD -0.211; TCGA PRAD -0.147; TCGA THCA -0.128 |
hsa-miR-338-3p | SEC24D | 10 cancers: BRCA; HNSC; LGG; LIHC; OV; PAAD; PRAD; SARC; THCA; UCEC | miRanda | TCGA BRCA -0.073; TCGA HNSC -0.211; TCGA LGG -0.096; TCGA LIHC -0.198; TCGA OV -0.056; TCGA PAAD -0.179; TCGA PRAD -0.182; TCGA SARC -0.09; TCGA THCA -0.157; TCGA UCEC -0.116 |
hsa-miR-338-3p | PPFIBP1 | 9 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRP; PAAD; PRAD; STAD | miRanda | TCGA BRCA -0.105; TCGA CESC -0.108; TCGA COAD -0.083; TCGA ESCA -0.165; TCGA HNSC -0.11; TCGA KIRP -0.271; TCGA PAAD -0.244; TCGA PRAD -0.112; TCGA STAD -0.078 |
hsa-miR-338-3p | TBX18 | 10 cancers: BRCA; ESCA; HNSC; LGG; LUAD; LUSC; OV; SARC; STAD; UCEC | miRanda | TCGA BRCA -0.236; TCGA ESCA -0.591; TCGA HNSC -0.259; TCGA LGG -0.076; TCGA LUAD -0.251; TCGA LUSC -0.578; TCGA OV -0.238; TCGA SARC -0.281; TCGA STAD -0.429; TCGA UCEC -0.256 |
hsa-miR-338-3p | RUNX1 | 11 cancers: BRCA; ESCA; HNSC; LGG; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | miRanda | TCGA BRCA -0.098; TCGA ESCA -0.183; TCGA HNSC -0.164; TCGA LGG -0.195; TCGA LUSC -0.053; TCGA OV -0.115; TCGA PAAD -0.296; TCGA PRAD -0.078; TCGA THCA -0.596; TCGA STAD -0.093; TCGA UCEC -0.171 |
hsa-miR-338-3p | HEY2 | 10 cancers: BRCA; CESC; COAD; ESCA; KIRP; LGG; LIHC; SARC; STAD; UCEC | miRanda | TCGA BRCA -0.147; TCGA CESC -0.182; TCGA COAD -0.13; TCGA ESCA -0.273; TCGA KIRP -0.177; TCGA LGG -0.097; TCGA LIHC -0.328; TCGA SARC -0.406; TCGA STAD -0.157; TCGA UCEC -0.162 |
hsa-miR-338-3p | PRICKLE1 | 9 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; THCA; STAD | miRanda | TCGA BRCA -0.273; TCGA CESC -0.22; TCGA COAD -0.183; TCGA ESCA -0.62; TCGA HNSC -0.221; TCGA KIRC -0.172; TCGA KIRP -0.469; TCGA THCA -0.289; TCGA STAD -0.311 |
hsa-miR-338-3p | PTK7 | 10 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUSC; PAAD; STAD | miRanda | TCGA BRCA -0.214; TCGA CESC -0.142; TCGA COAD -0.196; TCGA ESCA -0.383; TCGA HNSC -0.134; TCGA KIRC -0.13; TCGA LGG -0.194; TCGA LUSC -0.182; TCGA PAAD -0.148; TCGA STAD -0.229 |
hsa-miR-338-3p | TGFBR1 | 9 cancers: BRCA; COAD; HNSC; KIRC; LGG; LUAD; PRAD; THCA; STAD | miRanda | TCGA BRCA -0.165; TCGA COAD -0.093; TCGA HNSC -0.098; TCGA KIRC -0.097; TCGA LGG -0.091; TCGA LUAD -0.054; TCGA PRAD -0.143; TCGA THCA -0.263; TCGA STAD -0.068 |
hsa-miR-338-3p | ZFPM2 | 10 cancers: BRCA; CESC; ESCA; HNSC; LUAD; OV; PAAD; SARC; STAD; UCEC | miRanda | TCGA BRCA -0.266; TCGA CESC -0.253; TCGA ESCA -0.261; TCGA HNSC -0.192; TCGA LUAD -0.091; TCGA OV -0.149; TCGA PAAD -0.228; TCGA SARC -0.247; TCGA STAD -0.332; TCGA UCEC -0.171 |
hsa-miR-338-3p | ZNF532 | 11 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUSC; PAAD; SARC; THCA; STAD | miRanda | TCGA BRCA -0.105; TCGA CESC -0.184; TCGA COAD -0.11; TCGA ESCA -0.327; TCGA HNSC -0.198; TCGA KIRP -0.111; TCGA LUSC -0.182; TCGA PAAD -0.133; TCGA SARC -0.154; TCGA THCA -0.059; TCGA STAD -0.213 |
hsa-miR-338-3p | ARSB | 10 cancers: BRCA; COAD; HNSC; LIHC; LUAD; PAAD; PRAD; SARC; THCA; STAD | miRanda | TCGA BRCA -0.093; TCGA COAD -0.156; TCGA HNSC -0.243; TCGA LIHC -0.111; TCGA LUAD -0.098; TCGA PAAD -0.148; TCGA PRAD -0.095; TCGA SARC -0.054; TCGA THCA -0.134; TCGA STAD -0.146 |
hsa-miR-338-3p | RNF144A | 10 cancers: BRCA; CESC; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; THCA; STAD | miRanda | TCGA BRCA -0.186; TCGA CESC -0.146; TCGA ESCA -0.191; TCGA HNSC -0.197; TCGA LUAD -0.087; TCGA LUSC -0.111; TCGA PAAD -0.153; TCGA PRAD -0.063; TCGA THCA -0.241; TCGA STAD -0.136 |
hsa-miR-338-3p | DSE | 10 cancers: BRCA; CESC; ESCA; KIRC; LGG; LUAD; PAAD; THCA; STAD; UCEC | miRanda | TCGA BRCA -0.111; TCGA CESC -0.104; TCGA ESCA -0.365; TCGA KIRC -0.114; TCGA LGG -0.169; TCGA LUAD -0.099; TCGA PAAD -0.165; TCGA THCA -0.174; TCGA STAD -0.082; TCGA UCEC -0.073 |
hsa-miR-338-3p | PLS3 | 12 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; PAAD; SARC; THCA; STAD | miRanda | TCGA BRCA -0.156; TCGA CESC -0.165; TCGA COAD -0.089; TCGA ESCA -0.39; TCGA HNSC -0.071; TCGA KIRC -0.179; TCGA LIHC -0.084; TCGA LUAD -0.059; TCGA PAAD -0.261; TCGA SARC -0.157; TCGA THCA -0.186; TCGA STAD -0.106 |
hsa-miR-338-3p | APCDD1L | 10 cancers: BRCA; CESC; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; THCA; STAD | miRanda | TCGA BRCA -0.331; TCGA CESC -0.313; TCGA ESCA -0.664; TCGA HNSC -0.189; TCGA KIRC -0.643; TCGA LUAD -0.369; TCGA LUSC -0.624; TCGA PAAD -0.349; TCGA THCA -0.705; TCGA STAD -0.331 |
hsa-miR-338-3p | KLHL13 | 11 cancers: BRCA; CESC; ESCA; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; SARC; THCA | miRanda | TCGA BRCA -0.237; TCGA CESC -0.246; TCGA ESCA -0.553; TCGA HNSC -0.222; TCGA KIRC -0.571; TCGA LGG -0.133; TCGA LIHC -0.254; TCGA LUAD -0.104; TCGA LUSC -0.395; TCGA SARC -0.534; TCGA THCA -0.547 |
hsa-miR-338-3p | CDKAL1 | 9 cancers: BRCA; COAD; HNSC; LGG; LUAD; LUSC; PRAD; THCA; STAD | miRanda | TCGA BRCA -0.062; TCGA COAD -0.062; TCGA HNSC -0.065; TCGA LGG -0.093; TCGA LUAD -0.072; TCGA LUSC -0.149; TCGA PRAD -0.069; TCGA THCA -0.085; TCGA STAD -0.089 |
hsa-miR-338-3p | TET1 | 12 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; STAD | miRanda | TCGA BRCA -0.074; TCGA CESC -0.166; TCGA COAD -0.218; TCGA ESCA -0.33; TCGA HNSC -0.283; TCGA KIRP -0.103; TCGA LGG -0.119; TCGA LUAD -0.107; TCGA LUSC -0.399; TCGA PAAD -0.126; TCGA PRAD -0.148; TCGA STAD -0.146 |
hsa-miR-338-3p | SLC16A1 | 11 cancers: BRCA; CESC; ESCA; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA | miRanda | TCGA BRCA -0.133; TCGA CESC -0.148; TCGA ESCA -0.116; TCGA LGG -0.1; TCGA LIHC -0.259; TCGA LUAD -0.2; TCGA LUSC -0.363; TCGA PAAD -0.257; TCGA PRAD -0.15; TCGA SARC -0.119; TCGA THCA -0.226 |
hsa-miR-338-3p | SLC44A1 | 10 cancers: BRCA; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PAAD; PRAD; THCA | miRanda | TCGA BRCA -0.066; TCGA ESCA -0.101; TCGA HNSC -0.156; TCGA KIRC -0.115; TCGA LUAD -0.072; TCGA LUSC -0.193; TCGA OV -0.074; TCGA PAAD -0.275; TCGA PRAD -0.069; TCGA THCA -0.063 |
hsa-miR-338-3p | PTN | 9 cancers: BRCA; CESC; COAD; ESCA; LGG; OV; SARC; THCA; STAD | miRanda | TCGA BRCA -0.178; TCGA CESC -0.376; TCGA COAD -0.198; TCGA ESCA -0.452; TCGA LGG -0.076; TCGA OV -0.156; TCGA SARC -0.189; TCGA THCA -0.133; TCGA STAD -0.265 |
hsa-miR-338-3p | LTBP2 | 9 cancers: BRCA; ESCA; HNSC; LGG; OV; PAAD; PRAD; THCA; STAD | miRanda | TCGA BRCA -0.223; TCGA ESCA -0.177; TCGA HNSC -0.237; TCGA LGG -0.127; TCGA OV -0.149; TCGA PAAD -0.285; TCGA PRAD -0.136; TCGA THCA -0.188; TCGA STAD -0.268 |
hsa-miR-338-3p | DSC3 | 10 cancers: BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; THCA; STAD | miRanda | TCGA BRCA -0.452; TCGA CESC -1.272; TCGA COAD -0.491; TCGA ESCA -1.978; TCGA HNSC -0.267; TCGA LUAD -0.343; TCGA LUSC -1.078; TCGA PAAD -0.859; TCGA THCA -1.148; TCGA STAD -0.344 |
hsa-miR-338-3p | VCL | 9 cancers: BRCA; HNSC; LGG; LUAD; OV; PAAD; PRAD; SARC; THCA | miRanda | TCGA BRCA -0.097; TCGA HNSC -0.141; TCGA LGG -0.154; TCGA LUAD -0.064; TCGA OV -0.065; TCGA PAAD -0.177; TCGA PRAD -0.08; TCGA SARC -0.33; TCGA THCA -0.083 |
hsa-miR-338-3p | MBNL1 | 9 cancers: BRCA; CESC; ESCA; HNSC; PAAD; PRAD; SARC; THCA; UCEC | miRanda | TCGA BRCA -0.084; TCGA CESC -0.061; TCGA ESCA -0.135; TCGA HNSC -0.094; TCGA PAAD -0.079; TCGA PRAD -0.085; TCGA SARC -0.236; TCGA THCA -0.074; TCGA UCEC -0.051 |
hsa-miR-338-3p | IDH1 | 10 cancers: BRCA; HNSC; KIRC; LGG; LIHC; LUSC; PAAD; PRAD; THCA; UCEC | miRanda | TCGA BRCA -0.05; TCGA HNSC -0.091; TCGA KIRC -0.121; TCGA LGG -0.123; TCGA LIHC -0.134; TCGA LUSC -0.07; TCGA PAAD -0.14; TCGA PRAD -0.072; TCGA THCA -0.173; TCGA UCEC -0.104 |
hsa-miR-338-3p | KLF6 | 10 cancers: BRCA; CESC; KIRP; LGG; LIHC; PAAD; PRAD; SARC; THCA; UCEC | miRanda | TCGA BRCA -0.098; TCGA CESC -0.131; TCGA KIRP -0.159; TCGA LGG -0.051; TCGA LIHC -0.106; TCGA PAAD -0.18; TCGA PRAD -0.08; TCGA SARC -0.069; TCGA THCA -0.159; TCGA UCEC -0.091 |
hsa-miR-338-3p | FERMT2 | 11 cancers: BRCA; COAD; HNSC; LGG; LIHC; LUAD; OV; SARC; THCA; STAD; UCEC | miRanda | TCGA BRCA -0.166; TCGA COAD -0.251; TCGA HNSC -0.11; TCGA LGG -0.091; TCGA LIHC -0.076; TCGA LUAD -0.057; TCGA OV -0.075; TCGA SARC -0.28; TCGA THCA -0.05; TCGA STAD -0.26; TCGA UCEC -0.069 |
hsa-miR-338-3p | CACNA2D1 | 10 cancers: BRCA; CESC; COAD; HNSC; LUAD; LUSC; PRAD; THCA; STAD; UCEC | miRanda | TCGA BRCA -0.289; TCGA CESC -0.478; TCGA COAD -0.359; TCGA HNSC -0.585; TCGA LUAD -0.194; TCGA LUSC -0.27; TCGA PRAD -0.427; TCGA THCA -0.152; TCGA STAD -0.153; TCGA UCEC -0.223 |
hsa-miR-338-3p | CYP7B1 | 9 cancers: BRCA; CESC; ESCA; HNSC; KIRC; LIHC; LUAD; PRAD; STAD | miRanda | TCGA BRCA -0.139; TCGA CESC -0.421; TCGA ESCA -0.323; TCGA HNSC -0.127; TCGA KIRC -0.125; TCGA LIHC -0.43; TCGA LUAD -0.072; TCGA PRAD -0.174; TCGA STAD -0.258 |
hsa-miR-338-3p | LIMA1 | 10 cancers: BRCA; CESC; HNSC; KIRC; LGG; LUSC; PAAD; PRAD; THCA; UCEC | miRanda | TCGA BRCA -0.075; TCGA CESC -0.096; TCGA HNSC -0.086; TCGA KIRC -0.079; TCGA LGG -0.134; TCGA LUSC -0.116; TCGA PAAD -0.129; TCGA PRAD -0.101; TCGA THCA -0.243; TCGA UCEC -0.058 |
hsa-miR-338-3p | ANXA1 | 9 cancers: BRCA; CESC; ESCA; KIRP; LGG; OV; PAAD; THCA; UCEC | miRanda | TCGA BRCA -0.173; TCGA CESC -0.264; TCGA ESCA -0.631; TCGA KIRP -0.383; TCGA LGG -0.125; TCGA OV -0.118; TCGA PAAD -0.444; TCGA THCA -0.266; TCGA UCEC -0.18 |
hsa-miR-338-3p | AHNAK2 | 11 cancers: BRCA; CESC; ESCA; HNSC; KIRP; LUSC; OV; PAAD; SARC; THCA; STAD | miRanda | TCGA BRCA -0.097; TCGA CESC -0.262; TCGA ESCA -0.75; TCGA HNSC -0.158; TCGA KIRP -0.637; TCGA LUSC -0.401; TCGA OV -0.177; TCGA PAAD -0.529; TCGA SARC -0.215; TCGA THCA -0.655; TCGA STAD -0.345 |
hsa-miR-338-3p | GBP6 | 9 cancers: BRCA; CESC; ESCA; LGG; LUSC; OV; PAAD; THCA; STAD | miRanda | TCGA BRCA -0.279; TCGA CESC -1.287; TCGA ESCA -1.727; TCGA LGG -0.251; TCGA LUSC -0.784; TCGA OV -0.243; TCGA PAAD -0.323; TCGA THCA -0.432; TCGA STAD -0.562 |
hsa-miR-338-3p | PRRX1 | 13 cancers: BRCA; CESC; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; SARC; THCA; STAD; UCEC | miRanda | TCGA BRCA -0.229; TCGA CESC -0.246; TCGA ESCA -0.578; TCGA HNSC -0.191; TCGA LGG -0.138; TCGA LUAD -0.127; TCGA LUSC -0.195; TCGA OV -0.299; TCGA PAAD -0.35; TCGA SARC -0.179; TCGA THCA -0.137; TCGA STAD -0.207; TCGA UCEC -0.253 |
hsa-miR-338-3p | SMURF2 | 9 cancers: BRCA; COAD; HNSC; KIRP; LGG; LUAD; PAAD; PRAD; THCA | miRanda | TCGA BRCA -0.081; TCGA COAD -0.053; TCGA HNSC -0.119; TCGA KIRP -0.13; TCGA LGG -0.093; TCGA LUAD -0.08; TCGA PAAD -0.109; TCGA PRAD -0.117; TCGA THCA -0.156 |
hsa-miR-338-3p | LIMK1 | 10 cancers: BRCA; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; THCA; STAD | miRanda | TCGA BRCA -0.064; TCGA ESCA -0.262; TCGA HNSC -0.146; TCGA KIRC -0.137; TCGA KIRP -0.095; TCGA LUAD -0.076; TCGA LUSC -0.158; TCGA PAAD -0.138; TCGA THCA -0.16; TCGA STAD -0.093 |
hsa-miR-338-3p | FER | 10 cancers: BRCA; COAD; ESCA; HNSC; KIRP; LGG; LUAD; PAAD; PRAD; THCA | miRanda | TCGA BRCA -0.13; TCGA COAD -0.122; TCGA ESCA -0.154; TCGA HNSC -0.126; TCGA KIRP -0.123; TCGA LGG -0.103; TCGA LUAD -0.052; TCGA PAAD -0.243; TCGA PRAD -0.164; TCGA THCA -0.206 |
hsa-miR-338-3p | MYH9 | 11 cancers: BRCA; CESC; ESCA; HNSC; LUSC; OV; PAAD; PRAD; SARC; THCA; UCEC | miRanda | TCGA BRCA -0.055; TCGA CESC -0.078; TCGA ESCA -0.192; TCGA HNSC -0.21; TCGA LUSC -0.084; TCGA OV -0.085; TCGA PAAD -0.206; TCGA PRAD -0.061; TCGA SARC -0.163; TCGA THCA -0.201; TCGA UCEC -0.063 |
hsa-miR-338-3p | SVEP1 | 9 cancers: BRCA; CESC; COAD; ESCA; KIRC; PAAD; PRAD; STAD; UCEC | miRanda | TCGA BRCA -0.219; TCGA CESC -0.172; TCGA COAD -0.185; TCGA ESCA -0.235; TCGA KIRC -0.247; TCGA PAAD -0.341; TCGA PRAD -0.096; TCGA STAD -0.263; TCGA UCEC -0.249 |
hsa-miR-338-3p | MTAP | 9 cancers: BRCA; COAD; KIRP; LIHC; OV; PAAD; PRAD; SARC; THCA | miRanda | TCGA BRCA -0.075; TCGA COAD -0.07; TCGA KIRP -0.103; TCGA LIHC -0.068; TCGA OV -0.07; TCGA PAAD -0.182; TCGA PRAD -0.089; TCGA SARC -0.169; TCGA THCA -0.102 |
hsa-miR-338-3p | COL1A1 | 10 cancers: BRCA; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; THCA; UCEC | miRanda; miRNATAP | TCGA BRCA -0.208; TCGA ESCA -0.477; TCGA HNSC -0.504; TCGA LGG -0.451; TCGA LUAD -0.179; TCGA LUSC -0.49; TCGA OV -0.199; TCGA PAAD -0.474; TCGA THCA -0.596; TCGA UCEC -0.238 |
hsa-miR-338-3p | FZD7 | 10 cancers: BRCA; CESC; ESCA; HNSC; LGG; LUSC; PAAD; SARC; THCA; STAD | miRanda | TCGA BRCA -0.141; TCGA CESC -0.147; TCGA ESCA -0.34; TCGA HNSC -0.295; TCGA LGG -0.137; TCGA LUSC -0.349; TCGA PAAD -0.215; TCGA SARC -0.175; TCGA THCA -0.159; TCGA STAD -0.178 |
hsa-miR-338-3p | ADAM12 | 11 cancers: BRCA; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; THCA; UCEC | miRanda | TCGA BRCA -0.285; TCGA ESCA -0.665; TCGA HNSC -0.571; TCGA LGG -0.162; TCGA LUAD -0.318; TCGA LUSC -0.541; TCGA OV -0.241; TCGA PAAD -0.604; TCGA PRAD -0.12; TCGA THCA -0.537; TCGA UCEC -0.244 |
hsa-miR-338-3p | FAM126A | 10 cancers: BRCA; CESC; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; PRAD; THCA | miRanda | TCGA BRCA -0.214; TCGA CESC -0.233; TCGA ESCA -0.413; TCGA HNSC -0.09; TCGA KIRP -0.075; TCGA LGG -0.068; TCGA LIHC -0.122; TCGA LUAD -0.151; TCGA PRAD -0.146; TCGA THCA -0.126 |
hsa-miR-338-3p | MMP13 | 10 cancers: BRCA; CESC; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; THCA | miRanda | TCGA BRCA -0.352; TCGA CESC -0.743; TCGA ESCA -1.466; TCGA HNSC -0.319; TCGA LUAD -0.358; TCGA LUSC -0.823; TCGA OV -0.548; TCGA PAAD -0.74; TCGA PRAD -0.194; TCGA THCA -1.089 |
hsa-miR-338-3p | COL12A1 | 10 cancers: BRCA; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; THCA; UCEC | miRanda | TCGA BRCA -0.212; TCGA ESCA -0.233; TCGA HNSC -0.302; TCGA LGG -0.105; TCGA LUAD -0.264; TCGA LUSC -0.233; TCGA OV -0.174; TCGA PAAD -0.499; TCGA THCA -0.311; TCGA UCEC -0.128 |
hsa-miR-338-3p | ABCA13 | 9 cancers: BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; LUSC; PAAD | miRanda | TCGA BRCA -0.253; TCGA CESC -0.683; TCGA ESCA -0.777; TCGA HNSC -0.525; TCGA KIRC -1.139; TCGA KIRP -0.476; TCGA LGG -0.221; TCGA LUSC -0.515; TCGA PAAD -0.283 |
hsa-miR-338-3p | TNN | 9 cancers: BRCA; CESC; COAD; HNSC; LUSC; OV; PAAD; STAD; UCEC | miRanda | TCGA BRCA -0.263; TCGA CESC -0.287; TCGA COAD -0.188; TCGA HNSC -0.179; TCGA LUSC -0.191; TCGA OV -0.166; TCGA PAAD -0.219; TCGA STAD -0.306; TCGA UCEC -0.139 |
hsa-miR-338-3p | GBP2 | 9 cancers: BRCA; CESC; LGG; LUAD; OV; PAAD; SARC; THCA; UCEC | miRanda | TCGA BRCA -0.132; TCGA CESC -0.193; TCGA LGG -0.288; TCGA LUAD -0.06; TCGA OV -0.208; TCGA PAAD -0.299; TCGA SARC -0.255; TCGA THCA -0.466; TCGA UCEC -0.091 |
hsa-miR-338-3p | NIN | 9 cancers: BRCA; CESC; ESCA; HNSC; KIRP; LUAD; PRAD; THCA; STAD | miRanda | TCGA BRCA -0.063; TCGA CESC -0.132; TCGA ESCA -0.33; TCGA HNSC -0.152; TCGA KIRP -0.115; TCGA LUAD -0.054; TCGA PRAD -0.09; TCGA THCA -0.159; TCGA STAD -0.084 |
hsa-miR-338-3p | LAMC2 | 10 cancers: BRCA; ESCA; HNSC; KIRC; KIRP; LUSC; PAAD; SARC; THCA; UCEC | miRanda | TCGA BRCA -0.192; TCGA ESCA -0.331; TCGA HNSC -0.211; TCGA KIRC -0.806; TCGA KIRP -0.458; TCGA LUSC -0.281; TCGA PAAD -0.554; TCGA SARC -0.152; TCGA THCA -0.358; TCGA UCEC -0.191 |
hsa-miR-338-3p | ULBP1 | 9 cancers: BRCA; CESC; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; THCA | miRanda | TCGA BRCA -0.251; TCGA CESC -0.347; TCGA ESCA -0.292; TCGA HNSC -0.368; TCGA LGG -0.258; TCGA LUAD -0.147; TCGA LUSC -0.192; TCGA PAAD -0.308; TCGA THCA -0.132 |
hsa-miR-338-3p | CHSY3 | 9 cancers: BRCA; CESC; ESCA; HNSC; LIHC; LUAD; OV; PAAD; THCA | miRanda | TCGA BRCA -0.157; TCGA CESC -0.163; TCGA ESCA -0.221; TCGA HNSC -0.27; TCGA LIHC -0.112; TCGA LUAD -0.105; TCGA OV -0.156; TCGA PAAD -0.278; TCGA THCA -0.105 |
hsa-miR-338-3p | FAM168A | 9 cancers: BRCA; COAD; HNSC; LIHC; LUAD; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BRCA -0.084; TCGA COAD -0.113; TCGA HNSC -0.261; TCGA LIHC -0.12; TCGA LUAD -0.137; TCGA PAAD -0.204; TCGA PRAD -0.302; TCGA THCA -0.219; TCGA STAD -0.074 |
hsa-miR-338-3p | CDK6 | 10 cancers: BRCA; COAD; ESCA; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD | mirMAP | TCGA BRCA -0.192; TCGA COAD -0.074; TCGA ESCA -0.121; TCGA KIRP -0.136; TCGA LGG -0.124; TCGA LIHC -0.192; TCGA LUAD -0.155; TCGA LUSC -0.145; TCGA PAAD -0.224; TCGA PRAD -0.262 |
hsa-miR-338-3p | GLIS3 | 9 cancers: BRCA; HNSC; KIRC; KIRP; LGG; LUAD; PRAD; SARC; UCEC | mirMAP | TCGA BRCA -0.266; TCGA HNSC -0.284; TCGA KIRC -0.096; TCGA KIRP -0.157; TCGA LGG -0.179; TCGA LUAD -0.127; TCGA PRAD -0.154; TCGA SARC -0.225; TCGA UCEC -0.17 |
hsa-miR-338-3p | KRT80 | 10 cancers: BRCA; ESCA; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BRCA -0.174; TCGA ESCA -0.429; TCGA KIRC -0.592; TCGA KIRP -0.243; TCGA LUAD -0.16; TCGA LUSC -0.263; TCGA PAAD -0.468; TCGA PRAD -0.327; TCGA THCA -0.705; TCGA STAD -0.424 |
hsa-miR-338-3p | MEX3B | 12 cancers: BRCA; CESC; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.155; TCGA CESC -0.128; TCGA ESCA -0.423; TCGA HNSC -0.291; TCGA KIRP -0.149; TCGA LUAD -0.092; TCGA LUSC -0.325; TCGA PAAD -0.139; TCGA PRAD -0.078; TCGA SARC -0.238; TCGA STAD -0.198; TCGA UCEC -0.12 |
hsa-miR-338-3p | KREMEN1 | 10 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUSC; PRAD; STAD; UCEC | mirMAP | TCGA BRCA -0.097; TCGA CESC -0.36; TCGA COAD -0.124; TCGA ESCA -0.473; TCGA HNSC -0.2; TCGA KIRC -0.123; TCGA LUSC -0.312; TCGA PRAD -0.112; TCGA STAD -0.191; TCGA UCEC -0.097 |
hsa-miR-338-3p | PRELP | 9 cancers: BRCA; CESC; COAD; ESCA; HNSC; SARC; THCA; STAD; UCEC | mirMAP | TCGA BRCA -0.219; TCGA CESC -0.367; TCGA COAD -0.361; TCGA ESCA -0.28; TCGA HNSC -0.256; TCGA SARC -0.606; TCGA THCA -0.197; TCGA STAD -0.517; TCGA UCEC -0.29 |
hsa-miR-338-3p | MICAL3 | 9 cancers: BRCA; CESC; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; SARC | mirMAP | TCGA BRCA -0.114; TCGA CESC -0.057; TCGA ESCA -0.135; TCGA HNSC -0.118; TCGA KIRP -0.152; TCGA LIHC -0.067; TCGA LUAD -0.073; TCGA LUSC -0.241; TCGA SARC -0.294 |
hsa-miR-338-3p | CBL | 9 cancers: BRCA; HNSC; KIRP; LGG; LUAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BRCA -0.062; TCGA HNSC -0.174; TCGA KIRP -0.087; TCGA LGG -0.079; TCGA LUAD -0.052; TCGA PRAD -0.142; TCGA SARC -0.115; TCGA THCA -0.137; TCGA STAD -0.058 |
hsa-miR-338-3p | FBXO32 | 13 cancers: BRCA; CESC; COAD; ESCA; KIRC; LUAD; LUSC; OV; PAAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BRCA -0.179; TCGA CESC -0.183; TCGA COAD -0.147; TCGA ESCA -0.251; TCGA KIRC -0.134; TCGA LUAD -0.175; TCGA LUSC -0.3; TCGA OV -0.198; TCGA PAAD -0.307; TCGA SARC -0.524; TCGA THCA -0.384; TCGA STAD -0.211; TCGA UCEC -0.114 |
hsa-miR-338-3p | SMO | 10 cancers: CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; STAD | miRNAWalker2 validate; miRTarBase; PITA; miRanda | TCGA CESC -0.171; TCGA COAD -0.177; TCGA ESCA -0.686; TCGA HNSC -0.193; TCGA KIRC -0.221; TCGA KIRP -0.14; TCGA LGG -0.176; TCGA LUAD -0.134; TCGA LUSC -0.477; TCGA STAD -0.277 |
hsa-miR-338-3p | FAM69A | 11 cancers: CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC | MirTarget; miRanda; miRNATAP | TCGA CESC -0.17; TCGA COAD -0.091; TCGA ESCA -0.178; TCGA HNSC -0.1; TCGA KIRC -0.124; TCGA LIHC -0.091; TCGA LUAD -0.083; TCGA LUSC -0.166; TCGA PAAD -0.16; TCGA PRAD -0.111; TCGA SARC -0.191 |
hsa-miR-338-3p | VMA21 | 9 cancers: CESC; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; OV; PRAD | MirTarget; miRanda | TCGA CESC -0.057; TCGA ESCA -0.165; TCGA HNSC -0.06; TCGA KIRC -0.054; TCGA LGG -0.059; TCGA LUAD -0.096; TCGA LUSC -0.102; TCGA OV -0.061; TCGA PRAD -0.06 |
hsa-miR-338-3p | RAB30 | 11 cancers: CESC; COAD; HNSC; KIRC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA | MirTarget | TCGA CESC -0.109; TCGA COAD -0.155; TCGA HNSC -0.179; TCGA KIRC -0.128; TCGA LIHC -0.201; TCGA LUAD -0.108; TCGA LUSC -0.11; TCGA PAAD -0.228; TCGA PRAD -0.23; TCGA SARC -0.208; TCGA THCA -0.07 |
hsa-miR-338-3p | MCM4 | 10 cancers: CESC; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; PAAD; PRAD; THCA | MirTarget; miRanda | TCGA CESC -0.072; TCGA ESCA -0.204; TCGA HNSC -0.193; TCGA KIRC -0.136; TCGA LGG -0.082; TCGA LUAD -0.209; TCGA LUSC -0.449; TCGA PAAD -0.246; TCGA PRAD -0.117; TCGA THCA -0.273 |
hsa-miR-338-3p | SGTB | 9 cancers: CESC; COAD; ESCA; HNSC; LUAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA CESC -0.119; TCGA COAD -0.154; TCGA ESCA -0.175; TCGA HNSC -0.128; TCGA LUAD -0.093; TCGA PRAD -0.108; TCGA SARC -0.077; TCGA THCA -0.177; TCGA STAD -0.089 |
hsa-miR-338-3p | TTL | 9 cancers: CESC; COAD; ESCA; KIRC; LUAD; LUSC; PAAD; THCA; STAD | MirTarget; miRanda | TCGA CESC -0.095; TCGA COAD -0.07; TCGA ESCA -0.154; TCGA KIRC -0.149; TCGA LUAD -0.068; TCGA LUSC -0.095; TCGA PAAD -0.092; TCGA THCA -0.225; TCGA STAD -0.087 |
hsa-miR-338-3p | UBXN2A | 10 cancers: CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; THCA | miRanda | TCGA CESC -0.067; TCGA COAD -0.056; TCGA ESCA -0.145; TCGA HNSC -0.058; TCGA LGG -0.063; TCGA LUAD -0.077; TCGA LUSC -0.141; TCGA PAAD -0.09; TCGA PRAD -0.061; TCGA THCA -0.084 |
hsa-miR-338-3p | ARL6IP6 | 11 cancers: CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; THCA | miRanda | TCGA CESC -0.111; TCGA COAD -0.065; TCGA ESCA -0.233; TCGA HNSC -0.114; TCGA KIRP -0.151; TCGA LGG -0.097; TCGA LUAD -0.099; TCGA LUSC -0.173; TCGA PAAD -0.196; TCGA PRAD -0.054; TCGA THCA -0.102 |
hsa-miR-338-3p | SSX2IP | 9 cancers: CESC; HNSC; KIRC; LIHC; LUAD; LUSC; PRAD; SARC; THCA | miRanda | TCGA CESC -0.074; TCGA HNSC -0.088; TCGA KIRC -0.207; TCGA LIHC -0.191; TCGA LUAD -0.103; TCGA LUSC -0.206; TCGA PRAD -0.069; TCGA SARC -0.092; TCGA THCA -0.09 |
hsa-miR-338-3p | DR1 | 9 cancers: CESC; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; THCA | miRanda | TCGA CESC -0.144; TCGA ESCA -0.11; TCGA HNSC -0.062; TCGA LGG -0.051; TCGA LUAD -0.075; TCGA LUSC -0.084; TCGA PAAD -0.114; TCGA PRAD -0.086; TCGA THCA -0.148 |
hsa-miR-338-3p | PLK4 | 9 cancers: CESC; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; THCA | miRanda | TCGA CESC -0.066; TCGA ESCA -0.142; TCGA HNSC -0.095; TCGA LGG -0.1; TCGA LUAD -0.219; TCGA LUSC -0.373; TCGA PAAD -0.19; TCGA PRAD -0.09; TCGA THCA -0.106 |
hsa-miR-338-3p | ABHD4 | 10 cancers: CESC; ESCA; HNSC; KIRC; LGG; LUSC; OV; PAAD; THCA; STAD | miRanda | TCGA CESC -0.162; TCGA ESCA -0.195; TCGA HNSC -0.162; TCGA KIRC -0.207; TCGA LGG -0.11; TCGA LUSC -0.132; TCGA OV -0.059; TCGA PAAD -0.119; TCGA THCA -0.056; TCGA STAD -0.072 |
hsa-miR-338-3p | SNX18 | 10 cancers: CESC; COAD; ESCA; HNSC; KIRC; LIHC; PRAD; SARC; THCA; STAD | miRanda | TCGA CESC -0.082; TCGA COAD -0.093; TCGA ESCA -0.125; TCGA HNSC -0.075; TCGA KIRC -0.123; TCGA LIHC -0.057; TCGA PRAD -0.094; TCGA SARC -0.149; TCGA THCA -0.089; TCGA STAD -0.084 |
hsa-miR-338-3p | E2F7 | 11 cancers: CESC; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA | miRanda | TCGA CESC -0.222; TCGA ESCA -0.365; TCGA HNSC -0.293; TCGA KIRP -0.15; TCGA LGG -0.211; TCGA LUAD -0.242; TCGA LUSC -0.699; TCGA PAAD -0.477; TCGA PRAD -0.205; TCGA SARC -0.164; TCGA THCA -0.21 |
hsa-miR-338-3p | UBE2W | 10 cancers: CESC; COAD; HNSC; KIRC; LUAD; OV; PAAD; PRAD; SARC; THCA | miRanda | TCGA CESC -0.061; TCGA COAD -0.094; TCGA HNSC -0.085; TCGA KIRC -0.151; TCGA LUAD -0.074; TCGA OV -0.069; TCGA PAAD -0.094; TCGA PRAD -0.139; TCGA SARC -0.055; TCGA THCA -0.111 |
hsa-miR-338-3p | ZNF286B | 9 cancers: CESC; HNSC; KIRP; LGG; LUAD; LUSC; SARC; STAD; UCEC | miRanda | TCGA CESC -0.077; TCGA HNSC -0.132; TCGA KIRP -0.12; TCGA LGG -0.101; TCGA LUAD -0.069; TCGA LUSC -0.17; TCGA SARC -0.137; TCGA STAD -0.088; TCGA UCEC -0.138 |
hsa-miR-338-3p | CNTLN | 9 cancers: CESC; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; SARC | miRanda | TCGA CESC -0.17; TCGA COAD -0.229; TCGA ESCA -0.536; TCGA HNSC -0.144; TCGA KIRP -0.196; TCGA LGG -0.122; TCGA LIHC -0.104; TCGA LUAD -0.127; TCGA SARC -0.15 |
hsa-miR-338-3p | NUP205 | 10 cancers: CESC; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; THCA | miRanda | TCGA CESC -0.056; TCGA ESCA -0.132; TCGA HNSC -0.183; TCGA KIRP -0.078; TCGA LGG -0.148; TCGA LUAD -0.102; TCGA LUSC -0.208; TCGA PAAD -0.066; TCGA PRAD -0.107; TCGA THCA -0.06 |
hsa-miR-338-3p | CENPW | 9 cancers: CESC; ESCA; LGG; LUAD; LUSC; OV; PAAD; SARC; THCA | miRanda | TCGA CESC -0.236; TCGA ESCA -0.298; TCGA LGG -0.118; TCGA LUAD -0.201; TCGA LUSC -0.337; TCGA OV -0.117; TCGA PAAD -0.184; TCGA SARC -0.184; TCGA THCA -0.166 |
hsa-miR-338-3p | ISM2 | 9 cancers: CESC; ESCA; HNSC; KIRC; LUAD; LUSC; SARC; THCA; STAD | mirMAP | TCGA CESC -0.31; TCGA ESCA -0.567; TCGA HNSC -0.319; TCGA KIRC -0.935; TCGA LUAD -0.271; TCGA LUSC -0.738; TCGA SARC -0.217; TCGA THCA -0.194; TCGA STAD -0.34 |
hsa-miR-338-3p | CBX6 | 9 cancers: CESC; COAD; ESCA; HNSC; LUAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA CESC -0.176; TCGA COAD -0.281; TCGA ESCA -0.173; TCGA HNSC -0.307; TCGA LUAD -0.094; TCGA PRAD -0.107; TCGA SARC -0.167; TCGA THCA -0.187; TCGA STAD -0.344 |
hsa-miR-338-3p | EYA3 | 9 cancers: CESC; HNSC; KIRC; LGG; LIHC; LUSC; PAAD; PRAD; THCA | miRNATAP | TCGA CESC -0.093; TCGA HNSC -0.128; TCGA KIRC -0.15; TCGA LGG -0.111; TCGA LIHC -0.121; TCGA LUSC -0.068; TCGA PAAD -0.136; TCGA PRAD -0.17; TCGA THCA -0.156 |
hsa-miR-338-3p | RRM1 | 10 cancers: CESC; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA | miRNATAP | TCGA CESC -0.08; TCGA ESCA -0.174; TCGA HNSC -0.076; TCGA LGG -0.077; TCGA LUAD -0.106; TCGA LUSC -0.271; TCGA PAAD -0.116; TCGA PRAD -0.056; TCGA SARC -0.079; TCGA THCA -0.157 |
hsa-miR-338-3p | ITGB3 | 10 cancers: COAD; HNSC; KIRC; LGG; LIHC; LUAD; OV; PAAD; SARC; THCA | miRanda | TCGA COAD -0.147; TCGA HNSC -0.269; TCGA KIRC -0.171; TCGA LGG -0.264; TCGA LIHC -0.216; TCGA LUAD -0.145; TCGA OV -0.202; TCGA PAAD -0.329; TCGA SARC -0.245; TCGA THCA -0.239 |
hsa-miR-338-3p | AZIN1 | 9 cancers: COAD; HNSC; KIRC; LUAD; LUSC; OV; PAAD; PRAD; THCA | miRanda | TCGA COAD -0.068; TCGA HNSC -0.137; TCGA KIRC -0.086; TCGA LUAD -0.105; TCGA LUSC -0.091; TCGA OV -0.105; TCGA PAAD -0.096; TCGA PRAD -0.124; TCGA THCA -0.056 |
hsa-miR-338-3p | PHKA1 | 11 cancers: COAD; ESCA; KIRC; LGG; LIHC; LUAD; LUSC; PRAD; SARC; THCA; STAD | miRanda | TCGA COAD -0.119; TCGA ESCA -0.111; TCGA KIRC -0.194; TCGA LGG -0.085; TCGA LIHC -0.12; TCGA LUAD -0.067; TCGA LUSC -0.196; TCGA PRAD -0.087; TCGA SARC -0.264; TCGA THCA -0.062; TCGA STAD -0.175 |
hsa-miR-338-3p | PRSS23 | 10 cancers: COAD; LGG; LUAD; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRanda | TCGA COAD -0.248; TCGA LGG -0.071; TCGA LUAD -0.13; TCGA OV -0.125; TCGA PAAD -0.25; TCGA PRAD -0.09; TCGA SARC -0.148; TCGA THCA -0.386; TCGA STAD -0.172; TCGA UCEC -0.137 |
hsa-miR-338-3p | ARMC1 | 10 cancers: COAD; HNSC; KIRC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA | miRanda | TCGA COAD -0.056; TCGA HNSC -0.089; TCGA KIRC -0.084; TCGA LUAD -0.093; TCGA LUSC -0.092; TCGA OV -0.058; TCGA PAAD -0.117; TCGA PRAD -0.127; TCGA SARC -0.119; TCGA THCA -0.106 |
hsa-miR-338-3p | TTC30A | 9 cancers: COAD; HNSC; KIRC; LGG; LIHC; LUSC; PRAD; SARC; STAD | miRanda | TCGA COAD -0.119; TCGA HNSC -0.183; TCGA KIRC -0.13; TCGA LGG -0.074; TCGA LIHC -0.143; TCGA LUSC -0.071; TCGA PRAD -0.161; TCGA SARC -0.063; TCGA STAD -0.184 |
hsa-miR-338-3p | MKX | 10 cancers: COAD; ESCA; KIRC; LUAD; OV; PAAD; PRAD; SARC; THCA; STAD | miRanda | TCGA COAD -0.326; TCGA ESCA -0.331; TCGA KIRC -0.538; TCGA LUAD -0.208; TCGA OV -0.204; TCGA PAAD -0.339; TCGA PRAD -0.112; TCGA SARC -0.335; TCGA THCA -0.169; TCGA STAD -0.281 |
hsa-miR-338-3p | PDK1 | 9 cancers: ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA | miRanda | TCGA ESCA -0.16; TCGA HNSC -0.221; TCGA LIHC -0.109; TCGA LUAD -0.103; TCGA LUSC -0.364; TCGA PAAD -0.108; TCGA PRAD -0.102; TCGA SARC -0.122; TCGA THCA -0.183 |
hsa-miR-338-3p | OGFOD1 | 9 cancers: ESCA; KIRC; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | miRanda | TCGA ESCA -0.098; TCGA KIRC -0.188; TCGA LIHC -0.074; TCGA LUAD -0.05; TCGA LUSC -0.071; TCGA PAAD -0.085; TCGA PRAD -0.052; TCGA THCA -0.088; TCGA UCEC -0.081 |
hsa-miR-338-3p | XRCC2 | 9 cancers: ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; THCA | miRanda | TCGA ESCA -0.193; TCGA HNSC -0.209; TCGA KIRP -0.198; TCGA LGG -0.173; TCGA LUAD -0.18; TCGA LUSC -0.547; TCGA PAAD -0.184; TCGA PRAD -0.142; TCGA THCA -0.139 |
hsa-miR-338-3p | FAM120A | 9 cancers: HNSC; LGG; LIHC; LUSC; OV; PAAD; PRAD; THCA; UCEC | MirTarget; miRanda; miRNATAP | TCGA HNSC -0.085; TCGA LGG -0.051; TCGA LIHC -0.082; TCGA LUSC -0.062; TCGA OV -0.054; TCGA PAAD -0.058; TCGA PRAD -0.097; TCGA THCA -0.088; TCGA UCEC -0.075 |
hsa-miR-338-3p | FAM111B | 9 cancers: HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA | MirTarget; miRanda | TCGA HNSC -0.118; TCGA KIRP -0.213; TCGA LGG -0.273; TCGA LUAD -0.245; TCGA LUSC -0.46; TCGA PAAD -0.323; TCGA PRAD -0.219; TCGA SARC -0.264; TCGA THCA -0.451 |
Enriched cancer pathways of putative targets